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The human gut microbiome contains an abundance of microorganisms which 
could influence mental health as well as physical health. These microorganisms produce 
chemicals which affect the brain and the body in various ways. Probiotic bacteria and 
yeasts have been studied to determine effects they have on mice, rats, and humans to 
illustrate the importance these microorganisms on health. Studies have shown that adding 
beneficial microorganisms to the human diet can have positive effects on mental and 
physical health, to include lessening symptoms of depression and anxiety, lessen gastro-
intestinal inflammation, displacing pathogens, and improving immunomodulatory 
response.  A quantitative way to identify these microorganisms would be beneficial for 
future research and future use. Utilizing quantitative polymerase chain reaction, qPCR, to 
identify and quantify these probiotic microorganisms, and the data required to create 
assays and standard curves, it is possible to estimate the quantity of DNA of the 
associated bacteria from a sample. Methods, procedures, and materials were created or 
compiled for the purpose of growing the species, extracting the DNA, and amplifying the 
DNA via qPCR. These methods, procedures, materials, and the data and the standard 
curves created from qPCR were all compiled into a reference guide helpful in identifying 
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DETECTION AND QUANTIFICATION OF BACTERIAL SPECIES 
IMPORTANT TO MENTAL AND PHYSICAL HEALTH  
 
Chapter 1:  Introduction 
Background 
Recently, a multitude of research has been conducted to understand the gut-brain 
axis, specifically the connection of the microbiome and its related compounds to physical 
performance, cognitive ability, and mental health. Through diet or supplement, numerous 
studies suggest these microorganisms produce a variety of chemicals that affect systemic 
inflammation, neuroinflammation, cognitive function, and emotional behavior [1]. 
Beyond the chemicals that affect mental and physical health, some microorganisms can 
effect serotonin production [2] or release dopamine [3]. Humans have existed and 
developed alongside these microorganisms to where a symbiosis exists [4]. A category of 
foods that has the potential to contain large quantities of these probiotic microorganisms 
is fermented food. Although humans have created fermented foods and beverages for 
thousands of years, people have changed their preference of preserving from fermentation 
to chemically preserving foods [5]. The change in preserving left many people without 
these foods and microorganisms in their typical diet. Due to the resurgence of home 
preserving and more traditional ways of preparing food, it is necessary to identify the 
microorganisms to which people may be exposed. Members within the various branches 
of the Department of Defense are exposed to multitudes of stressors, pathogens, and 
environments, all of which effect mental and physical readiness.  
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Problem Statement 
Despite advancement in research regarding the gut microbiome and the 
connection to mental and physical health, methods utilizing existing microbial tools to 
provide a comprehensive and accurate bacterial species level quantification of the 
potentially positive bacteria are missing.  The purpose of this research was to develop the 
methods and protocol for qPCR assays of multiple gut bacteria with species in the genera 
of Lactobacillus and Bifidobacterium.  
Research Objectives 
The end product of this thesis was to provide a reference guide to assist future 
research into these bacteria. In order to create this product, the following research 
objectives were accomplished. 
1) Identify microorganisms associated to be beneficial to human mental and 
physical health. 
2) Develop, test, and verify methods by which to grow, quantify cells, and 
extract DNA of the beneficial microorganisms as well as primers and methods 
to create qPCR assays. 
3) Compile a reference guide containing all methods, materials, melt curves, 





Chapter 2, “Review of Microorganisms, Fermented Foods, and Health Benefits,” 
is a comprehensive review of current academic literature in regards to fermented foods 
and beverages, their associated microorganisms, and the possible health benefits 
conferred.  This article investigates the biological processes by which the microorganisms 
responsible for fermentation may convey benefits to individuals. Furthermore, various 
fermented foods are investigated to determine what effects they may have on health. 
Finally, Chapter 2 summarizes the microorganisms and associated effects on mental and 
physical health. The target journal for this paper is Journal of Food Science and 
Technology. 
Chapter 3, “Quantitative PCR Assays to Identify and Quantify Lactobacillus and 
Bifidobacterium Species Which Affect Mental and Physical Health,” provides details on 
the methods, materials, and procedure used to create the qPCR assays. Based on research 
in Chapter 2 and procurement time, nine bacteria with species in the genera of 
Lactobacillus and Bifidobacterium were grown and amplified.  All nine species were 
grown, DNA was extracted, and qPCR was performed in triplicate for each step. Upon 
completion of qPCR, standard curves and the corresponding equations were created. 
Finally, amplification curve plots, melt curve plots, and standard curve plots were 
compiled with all methods and materials to create a reference guide in the form of data 
sheets for future research. The target journal for this paper is Journal of DoD Research 
and Engineering. 
Chapter 4, “qPCR Data Sheets for Immunomodulatory Bacteria,” displays the end 
product from all the research in Chapter 2 and all the experimentation in Chapter 3. The 
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methods, materials, and procedures to recreate the various plots and data have been 
compiled and organized for future research or future application. Although the results are 
listed in Chapter 4, the analysis of the results is in Chapter 3. The target journal for this 
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Chapter 2: Literature Review of Microorganisms, Fermented Foods, and Health 
Benefits 
Chapter Overview: 
The purpose of this chapter is to provide a comprehensive review of current 
academic literature regarding fermented foods and beverages, their associated 
microorganisms, and their possible health benefits.  This article investigates the 
biological processes by which the microorganisms responsible for fermentation may 
convey benefits to individuals, specifically the chemicals, butyrate, GABA, serotonin, 
and dopamine. Furthermore, various fermented foods and beverages of the western diet 
are investigated to determine what effects they may have on health. Finally, studies on 
microorganisms and their associated effects on mental and physical health are 
investigated and summarized.  This chapter provides the basis of what microorganisms 
are selected for qPCR in Chapter 3. 
Publication Intention: 
Title: Health Benefits of Fermented Foods conferred by their Microorganisms 
Responsible 
Publication: Journal of Food Science and Technology 
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Humans have been fermenting to create multitudes of other food and drink 
products for thousands of years. Fermented foods, via the microorganisms used to create 
them, provide benefits to the human microbiome. The microorganisms in the human gut 
influence mental health as well as physical health by production of chemicals which may 
affect the brain via transmission through multiple pathways including the vagus nerve. 
Transmission of chemicals by these methods could be the way microorganisms improve 
mood and lessen symptoms of depression and anxiety. A need has arisen in recent years 
to study the microorganisms responsible for fermented foods in the Western diet. 
Microorganisms have been studied in vitro, in vivo, and in humans to determine their 
effects on mental and physical health. A benefit of the fermentation process is the 
cultivation of these microorganisms, increasing the exposure of benefits to humans. 
Studies have shown that adding beneficial microorganisms to the human diet, like those 
found in fermented foods, can have positive effects on mental and physical health, to 
include lessening symptoms of depression and anxiety, lessen gastro-intestinal 
inflammation, displacing harmful microorganisms, and improving immunomodulatory 









For thousands of years, humans have fermented foods and beverages to preserve, 
alter the flavor, and provide health benefits.  From pickled vegetables and fruits, yogurt 
and cheese, to wine and beer, humans have experimented with fermenting a multitude of 
foods and beverages. Louis Pasteur was one of the first scientists to recognize the 
connection between microorganisms and their role in the fermentation process [1]. 
Fermentation is a biological process by which microorganisms, namely bacteria and 
yeast, consume sugars and carbohydrates to produce byproducts, such as alcohol, lactic 
acid, and carbon dioxide [2].  
Fermentation is vital to the production of cheese, yogurt, beer, wine, select bread, 
and certain sausages [3]. There is widespread consumption of these foods and a growing 
recognition of the potential health benefits of microorganisms on human health [4]. For 
example, milk fermented into cheese or yogurt decreases symptoms associated with 
lactose intolerance [4]. The foods and beverages created through fermentation have 
increased health benefits due in part to the microorganisms used in the process [5]. 
Probiotics are associated with fermented foods but are not all encompassing. Through the 
consumption of fermented foods, microorganisms transit into the human digestive tract 
and produce a variety of chemicals that affect the gut and brain.  These chemicals affect 
mood, decrease inflammation, and act as an antidepressant [1]. The purpose of this paper 
is to review fermented food and beverage health benefits, investigate the associated 
microorganisms, and summarize potential biological processes by which microorganisms 
may confer benefits to individuals. 
 
10 
Biological Processes by which Microorganisms Confer Benefits  
The human gut microbiome is influenced by foods people consume [1]. 
Microbiota and the effect on the gut-brain axis is a more extensive topic than the purpose 
of this paper, but a simplified explanation is needed to understand the method in which 
these microorganisms “communicate” with the brain. Brain function and gut function 
influence each other through chemical signals [6]. This influence can be mental 
depression and intestinal inflammation [6] or finishing a satisfying meal and a release of 
dopamine [7]. The vagus nerve is the conduit in which the chemical signals transfer back 
and forth between internal organs and the brain [1]. Chemicals produced by 
microorganisms in the gut can be transported to the brain through penetration of the gut 
epithelial wall, absorption by enteric nerves, and then conducted via the vagus nerve. 
These chemicals can also be absorbed into the blood stream during natural digestive 
processes for transportation to the brain [6].  The gut microorganisms considered 
beneficial produce vitamins, organic acids, which may reduce more harmful bacteria, and 
reinforce the epithelial barrier of the intestinal lining [3]. The epithelial barrier along the 
intestinal wall prevents antigens from passing into the blood stream, preventing 
pathogens from infecting the brain and the rest of the body. These microorganisms can 
also produce chemicals that effect mood, mental health, and physical health. Butyrate, 
gamma-Aminobutyric acid (GABA), dopamine, and serotonin are some of the chemicals 
that are secreted by gut microorganisms that affect mental and physical health [1].  
Butyrate is a chemical that can penetrate the blood brain barrier, induce a positive mood, 
act as an antidepressant, as well as decrease inflammation [1]. Some species of 
Bifidobacterium have the ability to produce butyrate. Butyrate affects the gut by 
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increased cell proliferation and differentiation, improved epithelial barrier function, 
stimulation of mucin synthesis, and is an anti-inflammatory agent [8]. Positive changes to 
insulin sensitivity, cholesterol sensitivity and regulation of fluid and electrolyte uptake 
are affected by butyrate [8]. Butyrate may also be important in the prevention and 
treatment of diet induced obesity and colon cancers [8]. 
Gamma-Aminobutyric acid (GABA) is the main inhibitory neurotransmitter of 
the central nervous system. Species of Lactobacillus and Bifidobacterium in the human 
gut have the ability to produce GABA. This tranquilizing neurotransmitter has been 
studied as a way to treat inflammatory bowel disease (IBS) [1] and depression [56]. The 
use of GABA in the treatment of depression has been successful in patients who, 
previously, treatments have not worked [9]. Changes in GABA and GABA receptors 
have also been observed to effect mood disorders, anxiety disorders, ability to overcome 
fear, and changes in spatial working memory [9].  
Serotonin and dopamine are neurotransmitters whose level fluctuations are 
associated with changes in the intensity of the symptoms associated with anxiety and 
depression [10], [11]. Serotonin is used by the body to regulate the nervous system, the 
gastro-intestinal system, the cardiovascular system, the respiratory system, and mood 
[10]. The production of serotonin requires tryptophan, a chemical that Bifidobacteria 
infantis produces [12]. Dopamine is used to induce reward effects for certain actions, like 
the contentment felt after consuming a good meal [7], and is produced by some species of 




Health benefits associated with fermented foods: 
In Western society, there has been both a resurgence of interest and a rising 
abundance of health benefit claims [14]. Yet, the pace of foundational academic research 
has lagged behind the commercial industry. Researchers have identified the need for in-
vitro, animal, and human studies on potential beneficial health impacts [14]-[16]. While 
there is not a consensus on the benefits, multiple fermented foods have been preliminarily 
studied to include yogurt and milk, kimchi and sauerkraut, wine, beer, kombucha, and 
pickled vegetables and fruits. 
Select microorganisms can utilize lactose as a substrate in yogurt and fermented 
milk, resulting in the proliferation of bacterial cells. Bacteria intentionally added for 
fermentation are often Lactobacillus bulgaricus and Streptococcus thermophiles, but 
other species of Lactobacillus and Bifidobacterium are used as well [15]. To ensure 
microbial consistency, the milk is sterilized before adding the desired microorganisms 
that convert the liquid into the intended product. There are multiple claims on the 
probiotic impacts of yogurt and milk. For example, a randomized, double blind study of 
64 men with type 2 diabetes mellitus, observed consumption of probiotic yogurt resulted 
in both antidiabetic and antioxidant outcomes compared to control [15]. In another 
probiotic milk drink study of 132 participants funded by Yakult, consumption of the 
drink improved the mood of subjects that were initially poor [16].  
Kimchi and sauerkraut are produced through the lactic fermentation of cabbage. 
Traditionally in Korea, naturally occurring lactic acid bacteria such as Lactobacillus 
plantarum, Lactobacillus brevis, Pediococcus cerevisiae, Streptococcus faecalis, and 
Leuconostoc mesenteroides ferment Napa cabbage into Kimchi [17]. Traditional German 
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sauerkraut is also produced utilizing naturally occurring lactic acid bacteria, L. 
mesenteroides, Leuconostoc fallax, L. plantarum, and L. brevis to ferment white cabbage. 
Although it is common to use naturally occurring bacteria, industrial processes have 
noted improved quality by the addition of Lactococcus lactis, Pediococcus dextrinicus, 
Lactobacillus sakei, L. plantarum, Lactobacillus casei, and Lactobacillus curvatus [18]. 
The process is similar to create kimchi and sauerkraut, only with variations on spices and 
accompanying ingredients. In one study, 22 participants demonstrated a significant 
correlation between a diet including fermented kimchi and decreased body fat, improved 
blood pressure, decreased fasting insulin levels, decreased fasting glucose levels, and 
decreased total cholesterol levels over a diet containing non-fermented kimchi [17]. 
Fermented kimchi was also shown to have an anti-obesity effect in mice fed a high fat 
diet. Lower levels of serum insulin, serum leptin, and epididymal fat were observed 
compared to the mice that consumed only a high fat diet [19]. Sauerkraut demonstrated 
anti-inflammatory effects, through the increased production of nitric oxide production 
inhibitors, as well as antioxidant effects in murine macrophages compared to non-
fermented cabbage [20]. 
Wine is a produced from the fermentation of fruit juice, most popularly grapes. 
The microorganism used in the production of wine is the yeast, Saccharomyces 
cerevisiae. Researchers attempted to determine the link between red wine consumption 
and lipopolysaccharide serum concentrations, which is associated with liver disease. The 
study concluded that while consumption of red wine does not directly reduce post meal 
lipopolysaccharide serum concentrations, it does increase the abundance of 
Bifidobacterium and Prevotella, which may in-turn lower lipopolysaccharide serum 
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concentrations [21]. Studies in moderate consumption of wine have also shown that is 
beneficial to the cardiovascular system [22]. Benefits to cardiovascular health were 
shown in a study on concentrations of inflammatory markers four hours after the 
consumption of wine. In addition, a significant correlation was demonstrated between 
wine consumption and the reduction of factors associated with the development of 
atherosclerosis such as blood pressure, plasma glucose, and LDL-cholesterol, [23]. In a 
longitudinal study on the connection between alcohol consumption and depression, 
13,619 university graduate students were administered biennial surveys about personal 
alcohol consumption and depression. Results showed a U-shaped correlation between 
alcohol consumption, primarily wine, and depression. Out of the four categories of 
alcohol consumption (none, minimal, moderate, heavy), moderate consumption displayed 
the lowest risk of depression [24]. 
Beer is produced from the fermentation of cereal grains and water. The yeasts 
used are Saccharomyces pastorianus and S. cerevisiae, depending on the type of beer 
brewed. A study on moderate beer consumption showed a protective effect on the 
cardiovascular system through the bolstering of the atheroprotective profile of HDL, 
which lessened cholesterol build up [25]. The association between change in HDL levels 
and alcohol consumption was also demonstrated in a longitudinal study of 71,379 
members of the Kailuan community in Tangshan City, China. That study illustrated 
moderate beer consumption was associated with lowering total cholesterol over light, 
heavy, or no consumption [26].  
Kombucha is an effervescent sweet tea beverage that has been brewed in China 
for over 2000 years [27]. The fermentation process uses a symbiotic culture of bacteria 
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and yeast to convert the sugars and tea into B-vitamins, gluconic acid, acetic acid, 
fructose, and trace amounts of alcohol.  Acetic acid bacteria, Acetobacter and 
Gluconacetobacter, are the majority of the bacteria active during the fermentation 
process, but Lactobacillus and other microorganisms can be found as well [27]. Multiple 
reviews denote health benefits such as anti-carcinogenic and anti-diabetic effects, 
treatments for gastric ulcers, high cholesterol, and liver detoxification for kombucha [27]-
[29]. Studies demonstrated that kombucha conferred anti-microbial properties, in-vitro 
[30], and prevented weight loss in diabetic rats [31] and mice [32].  
Pickled vegetables and fruit are created by soaking in a brine, a vinegar, or by 
fermentation for the purpose lowering the pH to limit bacterial growth to select species. 
When pickling by fermentation, the desired bacteria outcompete other present 
microorganisms due to resistance to low pH, high salt concentrations, and high alcohol 
concentrations [33]. The primary bacterial genera associated in the pickling of vegetables 
and fruit is Lactobacillus, which are naturally occurring on vegetables and fruit. During 
the fermentation pickling process, nutritional quality and digestibility are enhanced, while 
toxins and anti-nutritional compounds are lowered [33]. A study, utilizing mass 
spectrometry, was performed to determine the quantity of bioactive peptides in raw, 
acidified, and fermented pickled cucumbers. They discovered the quantity of peptides is 






Microorganisms Associated with Fermentation  
Due to similar processes of fermentation, the foods and beverages noted 
previously contain many of the same microorganisms. For example, Bifidobacterium, 
Lactobacillus, S. thermophilus, and S. cerevisiae are present in fermented foods and may 
have positive effects on human physical and mental health [1]. Studies on the 
consumption of foods containing these microorganisms, reduced gastro-intestinal 
inflammation [35]-[37], decreased symptoms of depression and anxiety [38]-[42], 
increased cognitive function [43], improved immunomodulatory response [44]-[45], and 
boosted overall mood [12], [13], [46]-[48]. A summary of some of the microorganisms 















Table 1. Associated Health Benefits of Select Microorganisms used in Fermentation 
Microorganisms Benefits  Reference 
Bifidobacterium bifidum 
reduction in functional gastrointestinal disorders, 
reduced psychological stress 
[35] 
Bifidobacterium breve 
prevent the growth of E. coli and Candida albicans, 
alleviates symptoms of diarrhea, lower anxiety levels 
in mice that were bred to be anxious, improve 
cognitive function, lower depression 
[1], [38], 
[43] 
Bifidobacteria infantis increases serotonin production [12] 
Bifidobacterium lactis 
improve symptoms of irritable bowel syndrome and 
improve mood when used with other psychobiotics 
[1], [46] 
Bifidobacterium longum 
anti-inflammatory, lower cholesterol, antioxidant, 
reduction anxiety, cortisol levels, depression, 





reduction in stress and fatigue effects, potential in 
stabilizing and fortifying the gastrointestinal system 
against disease and infection 
[36], [37] 
Lactobacillus brevis anti-inflammatory, alleviate symptoms of IBS [1], [49] 
Lactobacillus casei 
some effect on combating some of the issues 
associated with chronic fatigue syndrome 
[41] 
Lactobacillus helveticus 
lower blood pressure in those with hypertension, 
prevent anxiety and cognitive impairment, prevent 
inflammation and anxiety from a high fat diet, and 
fight pathogens, remove allergens, and enhance 
absorption of nutrients  
[50]-[53] 
Lactobacillus lactis improves mood  [47] 
Lactobacillus paracasei 
contracted common cold less, exhibited cold 




bolsters immune activity and improved stress 
management 
[44], [45] 
Lactobacillus reuteri anti-inflammatory, insulin modulation [54], [55] 
Lactobacillus rhamnosus GG fewer symptoms of depression and anxiety [42] 
Saccharomyces cerevisiae anti-stress, anti-fatigue [56] 
Streptococcus thermophilus treats diarrhea symptoms, increases healthy gut flora [37] 




The Bifidobacterium genera of bacteria are found in fermented food, either 
through natural occurrence or being added to aid the fermentation process.  Studies have 
shown that it has positive effects on mental and physical health. Bifidobacterium bifidum, 
commonly detected in yogurts and fermented milk products, has been investigated as a 
potential probiotic in promotion of health [1]. In an open label study of 37 patients with 
functional gastrointestinal disorders, participants were administered fermented milk 
containing B. bifidum for four weeks. Upon conclusion of the study, the researchers 
correlated consumption of B. bifidum to a reduction of functional gastrointestinal 
disorders and reduced psychological stress [35]. Another species of Bifidobacterium, 
Bifidobacterium breve, can also be found in fermented milk drinks [1].  B. breve 
demonstrated that it prevents the growth of Escherichia coli and Candida albicans, which 
reduced symptoms associated with diarrhea [1]. B. breve also lowered the anxiety and 
depression symptoms in people diagnosed with schizophrenia [38] and in an Alzheimer’s 
disease mouse model, increased cognitive function [43]. Bifidobacterium lactis, can also 
be found in fermented milk drinks and yogurts. B. lactis can decrease bloating symptoms 
associated with irritable bowel syndrome [46]. Bifidobacterium longum, can be found in 
yogurts and fermented milk drinks. B. longum in the human gut may lower cholesterol, 
have antioxidant properties, reduce anxiety, and reduce depression [1]. Consumption of 
B. longum was demonstrated beneficial in the management of stress by score changes of 
three questionnaires taken after a social stressor inducing game [39].  B. longum was 
administered to swimmers in a double-blind study and the results gathered from blood 
serum and saliva showed a decrease in anti-inflammatory cytokine IL-1ra, improved 
cognition, and self-reported faster physical recovery [40].  
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The Lactobacillus genera of lactic acid bacteria can also be found in fermented 
food. Lactobacillus acidophilus is in fermented milk drinks, kimchi, sauerkraut, and 
yogurt. A study examined chronic fatigue syndrome via a forced swim test observed rats 
who consumed L. acidophilus had a reduction in stress and fatigue effects [36]. L. 
acidophilus aids in the protection of the gastrointestinal system against disease and 
infection through production of lactic acid and other organic acids [37]. L. brevis, can be 
found in bread, pickles, kimchi, sauerkraut and fermented milk drinks [1]. In a 
randomized, double-blind study to determine the interaction between L. brevis and 
symptoms of irritable bowel syndrome, individuals who took L. brevis had higher serum 
anti-inflammatory cytokines and decreased abdominal pain compared to the placebo 
group [49].  Another Lactobacillus bacterium, L. casei is found in yogurt and cheeses. A 
randomized, double-blind study investigating the effects of L. casei strain Shirota on 
chronic fatigue syndrome (CFS) was conducted on 39 patients. CFS symptoms include 
persistent fatigue, cognitive dysfunction, headaches, anxiety, and depression [41]. The 
study showed that L. casei Shirota affected some of the issues associated with CFS 
through changes in Beck Depression Inventory and Beck Anxiety Inventory scores 
associated with a decrease in anxiety over the course of the study [41]. Lactobacillus 
helveticus, formerly known as Lactobacillus delbrueckii (bulgaricus), can be found in 
cheeses and fermented milk drinks [1]. L. helveticus prevented anxiety and cognitive 
impairment in rats [50], [51], prevented inflammation and anxiety that stem from a high 
fat diet [52], inhibited the growth of pathogens, and enhanced absorption of nutrients in 
mice [53]. L. lactis, can be found in cheeses, and fermented milk drinks [1] and is known 
to improve mood when given in combination with other types of healthy gut bacteria 
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[47]. Lactobacillus paracasei, can be found in fermented milk drinks, wine, some 
sausages, and some cheeses. In a randomized, double-blind study involving the 
susceptibility to the common cold, it was noted that subjects who took a supplement 
containing L. paracasei, were diagnosed with the common cold less often, where during 
the 12 week intervention, 61.4% of the placebo group reported occurrence of a cold, 53% 
of those taking the L. paracasei supplement reported occurrence of a cold.  Additionally, 
the participants administered L. paracasei and did get a cold, had reduced severity of 
symptoms compared to individuals who did not take the supplement [48]. Researchers 
also noted a positive mood lasting longer for the L. paracasei participants in comparison 
to the placebo group [48]. L. plantarum, can be found in some sausages, sauerkraut, 
pickles, and kimchi. L. plantarum was found to be beneficial to natural killer cells whose 
function is to destroy virally-infected cells assist and with other immune responses [45]. 
In a double-blind study involving 171 subjects with natural killer cell counts less than 
50%, it was found that the subjects who consumed the yogurt with L. plantarum 
HOKKAIDO showed an increase in natural killer cell activity and showed lower stress 
markers [44]. The yogurt containing L. plantarum HOKKAIDO may help with immune 
activity and with decrease the biological markers associated with stress. Another 
Lactobacillus microorganism, Lactobacillus reuteri, has shown promise in effecting 
insulin and c-peptide secretions, important to people who have issues with sugar 
regulation [54]. L. reuteri also has anti-inflammatory properties demonstrated in vivo and 
in vitro [55]. L. rhamnosus, can be found in fermented milk drinks as well as fermented 
oatmeal. In a double-bind study of postpartum depression in 423 women, it was found 
that the women who took the supplement containing L. rhamnosus during and after 
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pregnancy exhibited fewer symptoms of depression and anxiety than those taking the 
placebo [42].  The combined views of these studies indicate that Lactobacillus has 
promise as a probiotic to benefit human physical and mental health. 
There are other bacteria and yeasts commonly used to ferment food and drink to 
which health effects are not as well studied. For example, S. cerevisiae is yeast that can 
be found in wine, beer, bread, or in supplement form. A study on the anti-stress and anti-
fatigue effects of S. cerevisiae was performed on rats who consumed fermented rice bran. 
The study showed a correlation between the consumption of the fermented rice bran and 
anti-stress by the change in weight of the spleen, thyroid, thymus, and adrenal gland over 
the control. It also showed anti-fatigue effects over the control with extended 
performance times during the swim test [56]. S. thermophilus, is bacteria that can be 
found in yogurts, cheeses, and fermented milk drinks. S. thermophilus has shown 
beneficial in treating diarrhea and has a secondary benefit of increasing other healthy 
microorganisms, such as Bifidobacterium [37]. 
Beneficial microorganisms may work more efficiently as a community. When 
Bifidobacterium and Lactobacillus species were administered orally in a multispecies 
probiotic, a study demonstrated improved mood, as illustrated by changes in MRI 
measures [57]. The same study also noted positive changes in behavioral scores on self-
reported assessments to include LEIDS-r questionnaire [57], Positive and Negative 
Affect Schedule, Symptoms Checklist 90, Allgemine Depressionsskala [57]. Similar 





Studies performed utilizing in-vitro models, animal subjects, or human subjects 
demonstrated the benefits theses microorganisms can convey. Fermented foods, the 
microorganisms they contain, and the chemicals produced by those microorganisms are 
beneficial to those who consume them.  Fermented food, as the delivery method of 
providing probiotic microorganisms to the human gut microbiome, has shown to have 
positive effects on test subjects, but similar effects were shown with the administration of 
probiotic supplements. The benefit to utilizing food as the delivery method would be the 
abundance of and readily availability of fermented foods and beverages in the Western 
diet. Additional studies into fermented foods should provide more insight to further 
examine and expand how microorganisms affect mental and physical health. The need to 
identify and quantify the microorganisms associated with fermented foods exists. The 
benefits of adding these probiotic microorganisms to treatments can only be justified 
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Chapter 3: Quantitative PCR Assays to Identify and Quantify Lactobacillus and 
Bifidobacterium Species Which Affect Mental and Physical Health 
Chapter Overview: 
This chapter provides details on the methods, materials, and procedure used to 
create the qPCR assays. Details are illustrated for the growth, cell count, cell extraction, 
and DNA extraction of nine species of bacteria in the genera of Lactobacillus and 
Bifidobacterium.  The quantitative amplification of the DNA is illustrated as well as the 
methods required to replicate the qPCR. Upon completion of qPCR, standard curves and 
the corresponding equations were created. Amplification curve plots, melt curve plots, 
and standard curve plots were compiled with all methods and materials to create a 
reference guide for future research detailed in Chapter 4. Although the results are listed in 
Chapter 4, the analysis of the results is in Chapter 3. Finally, a discussion about the DNA 
quality and the efficiency of the standard curves provides insight into the repeatability 
and usability of the qPCR assays. 
Publication Intention: 
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Bifidobacterium Species Which Affect Mental and Physical Health 
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Microorganisms in the gut may effect mental and physical health. The use of 
fermented foods or probiotic bacteria in the treatment of these issues is the next step in 
holistic health management. It is necessary to have a quantitative way to identify these 
microorganisms to determine what exists in samples. Utilizing qPCR to identify and 
quantify them provides the assays and standard curves necessary to determine the 
presence and abundance of DNA from the associated bacteria in a sample. In order to 
have these assays and standard curves, the methods, procedures, and materials must be 
created or compiled.  Each species was grown, the cells counted, and DNA extracted, 
qualified, and quantified.  The DNA was amplified using primers determined through 
research into previous quantification and identification studies. Standard curves were 
plotted from the data created using QuantStudio 6 Flex software.  These equations, plots 
and the data created will be helpful in identifying and quantifying the bacteria potentially 












It is necessary to have a valid method of identifying and quantifying the gut 
microorganisms which hold the potential to convey positive effects to mental and 
physical health. A connection exists between the presence of these microorganisms in an 
individual’s gut and their mental and physical state [1]. The importance of taking a 
holistic approach to human health has been the subject of multiple reviews [2]-[4]. 
Studies on the possible benefits conferred by these microorganisms include, reduced 
gastro-intestinal inflammation [1],[5]-[9], decreased symptoms of depression and anxiety 
[10]-[12], increased cognitive function [11], [12], improved immunomodulatory response 
[13]-[16], and boosted overall mood [15]. Connecting the quantity of these probiotic 
microorganisms to the possible health benefits requires a way to identify and quantify 
them in a sample from the gut microbiome.  
Identification and quantification of the microorganisms in the gut microbiome is 
possible through the use of quantitative polymerase chain reaction (qPCR). After the 
review of multiple probiotic microorganisms that are found in the human gut, the species 
listed in Table 1 were selected. These microorganisms were selected for the following 
reasons: found in common foods, positive effects on mental and physical health [1], 
availability and lead time for procurement, and being considered generally recognized as 
safe (GRAS) through the Food and Drug Administration (FDA) [17]. Although, 
Lactobacillus brevis is not listed on the FDA GRAS list, it is considered a probiotic not 
subject to FDA guidelines [17]. Each of these microorganisms can be found in commons 
foods such as yogurt, cheeses, fermented sausages, and fermented vegetables [1].  
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Table 1. Associated Health Benefits of Select Microorganisms  
Microorganisms Benefits  References 
Bifidobacterium breve prevent the growth of E. coli and Candida albicans, 
alleviates symptoms associated with diarrhea, lower anxiety 
levels in mice that were bred to be anxious, improve 
cognitive function, lower depression 
[1], [6],  
[11] 
Lactobacillus acidophilus reduction in stress and fatigue effects, potential in 
stabilizing and fortifying the gastrointestinal system against 
disease and infection 
[7], [8] 
Lactobacillus brevis anti-inflammatory, alleviate symptoms of IBS [1], [9] 
Lactobacillus casei some effect on combating some of the issues associated 
with chronic fatigue syndrome 
[18] 
Lactobacillus delbrueckii  
sub. bulgaricus 
increase production of immature T cells enhancing immune 
response 
[14] 
Lactobacillus helveticus lower blood pressure in those with hypertension, prevent 
anxiety and cognitive impairment in animal models, 
prevent inflammation and anxiety that stem from a high fat 
diet, and fight pathogens, remove allergens, and enhance 
absorption of nutrients in mice 
[19], [12], 
[10], [15] 
Lactobacillus paracasei contracted common cold less, exhibited cold symptoms for 
shorter amount of time, effects on positive mood 
[16] 
Lactobacillus planetarium enhanced immune response and with dealing with stress [17], [20] 
Lactobacillus  
rhamnosus GG 
fewer symptoms of depression and anxiety [13] 
 
Polymerase chain reaction (PCR) is the process by which DNA is duplicated; the 
DNA undergoes multiple cycles of heating, until the strands separate; cooling, until 
primers bond to the strands; and extending the primers with a DNA polymerase [21]. 
Small concentrations of DNA can be amplified into larger quantities through the use of 
PCR. Quantitative polymerase chain reaction (qPCR) adds fluorescent probes to PCR 
testing, which can detect amplifications of the target DNA in the reaction vessel in real 
time [22]. The cycle threshold method and the standard curve method are ways to analyze 
the data created through the qPCR process [23]. The cycle threshold method measures the 
change in fluorescent signal of the reporter dye to the number of amplification cycles 
36 
undergone [24]. The standard curve method is an absolute quantification method that 
requires the amplification of serial dilutions of the same DNA [24]. The cycle threshold 
is plotted logarithmically against the quantity of DNA. This method provides an estimate 
DNA quantity based on the cycle threshold determined in future qPCR tests. Analyzing 
the melt curve at the end of the qPCR process allows the ability to verify the sample 
amplified is the targeted sample [25]. The melt curve can also serve as a quality check to 
verify if contaminants were present within a sample, since each DNA has its own 
temperature of dissociation. Multiple peaks in the melt curve indicate multiple strains of 
DNA. The use of qPCR can provide data to analyze the DNA according to the cycle 
threshold method, the standard curve method, and the production of melt curves. The data 
and plots created will be compiled into a technical reference guide that will assist in 
future research and application. 
This paper details the methods required to culture the bacterial species from a 
freeze-dried state, how the plating was performed, and how the species where extracted, 
creating a known bacterial dilution.  Furthermore, the methods and techniques required to 
extract and quantify the DNA utilizing qPCR are detailed. Finally, the process by which 
standard curves were created and the quality control method is identified. The purpose of 
this paper is to provide methods, materials, and procedures to create assays and standard 






Method and Materials 
Culture Growth 
Lactobacillus species were received freezes-dried and revived by combining with 
a broth. The broth, sterilized in an autoclave at 121ºC for 25 minutes, consisted of 5.5 g 
BD Difco™ Lactobacilli MRS Broth (Becton, Dickinson and Company, DIFCO 288130, 
Franklin Lakes, New Jersey) and 100 ml deionized water. Inoculation occurred by 
transferring 1 ml room-temperature broth to the vial containing the Lactobacillus species 
freeze-dried pellet. The aliquot of broth and Lactobacillus species was next transferred to 
a test tube with 4 ml of broth. A broth/agar mixture was used as a growth medium for 
each of the Lactobacillus cultures. The broth/agar mixture was created by mixing 27.5 g 
broth (BD 288130), 500 ml deionized water, and 7.5 g agar. The broth/agar mixture was 
sterilized in an autoclave at 121ºC for 40 minutes. Once cooled to room temperature, the 
broth/agar mixture and the inoculated broth were ready for plating. 
As with the Lactobacillus species, a broth was required to inoculate the 
Bifidobacterium cultures from a freeze-dried state. The broth, sterilized in an autoclave at 
121ºC for 25 minutes, was created by mixing 3.0 g Tryptic Soy Broth (Becton, Dickinson 
and Company, DIFCO 211825, Franklin Lakes, New Jersey) and 95 ml deionized water. 
The sterilized mixture was cooled to ~47ºC before gently mixing in 5 ml room 
temperature sheep’s blood (defibrinated), (ThermoFisher Scientific, R54012, Waltham, 
Massachusetts). Inoculation occurred by transferring 1 ml of the room-temperature 
broth/sheep’s blood mixture to the vial containing the Bifidobacterium species freeze-
dried pellet. Next the aliquot of broth/sheep’s blood and Bifidobacterium species was 
transferred to a test tube with 4 ml of broth/sheep’s blood. A broth/sheep’s blood/agar 
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mixture was used as a growth medium for each of the Bifidobacterium cultures. The 
broth/agar mixture was created by mixing 15.0 g broth (BD 211825), 7.5 g agar, and 475 
ml deionized water, then sterilized in an autoclave at 121ºC for 40 minutes. The 
broth/agar mixture was then cooled to ~47ºC before 25 mL of room temperature sheep 
blood (defibrinated) was gently mixed in. Once cooled to room temperature, the 
broth/sheep’s blood/agar mixture and the inoculated broth were ready for plating. 
Plating 
The method for plating each species is the same; the only change is in the growth 
media and species being cultured. 100 mm petri dish plate, (Fisherbrand, FB0875712, 
Waltham, Massachusetts), were used to grow each bacteria. The broth/agar mixture was 
heated to 55 ºC and 30 ml was poured onto three plates per species. Each plate was 
poured in such a manner as to ensure no bubbles were created. The plates were then 
placed into a 37 ºC incubator for three hours to dry. Once drying was complete, 0.1 ml of 
the inoculated broth was pipetted near an edge of the plate. A disposable sterile 
inoculating loop, (Globe Scientific, 2875-25, Mahwah, New Jersey), was used to 
inoculate the plates by dipping the loop into the broth and then spreading it onto the plate. 
Once inoculated, the plates, up to 12, were placed in an AnaeroPack System Jar 
(Mitsubishi Gas Chemical Company Inc, R685025, Tokyo, Japan) with an AnaeroPouch 
(Mitsubishi Gas Chemical Company Inc, R681001, Tokyo, Japan), and a RT Anaero-
Indicator (Mitsubishi Gas Chemical Company Inc, R684002, Tokyo, Japan) to provide an 
anaerobic environment for the cultures to grow.  The AnaeroPack System was sealed and 
placed in an incubator at 37 ºC for at least 48 hours or until sufficient growth was noted.  
Cell Extraction 
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The number of colonies on each plate was counted and segmented into groups of 
~200. A known dilution for each plate was created using 1 ml of Phosphate Buffered 
Saline (PBS) 10X solution (Fisher Bioreagents, BP399-1, Waltham, Massachusetts) and 
~200 colonies.  This sample was vortexed for 10 seconds or until thoroughly mixed. Cell 
counts were accomplished with three 6 µl measurements per dilution in a 4-Chip 
Hemocytometer (Bulldog Bio, DHC-N420, Portsmouth New Hampshire), and magnified 
40X with a Zeiss Axioskop 50 (Carl Zeiss Microscopy, Jena, Germany). The counts were 
made in an “X” pattern on the hemocytometer with the mean taken per chip. This 
provided a range of cell counts to determine the number of cells in each 1 ml dilution. 
The cell counts per species in cells per microliter are illustrated in Table 3. 
DNA Extraction 
The method from bacterial growth to DNA sample is illustrated in Figure 1. The 
DNA was extracted from each PBS and bacteria dilution using a DNeasy® PowerSoil® 
Pro Kit (QIAGEN, 47014, Hilden, Germany). Three 250 µl samples were taken from the 
dilution and processed in accordance with the DNeasy® PowerSoil® Pro Kit instructions 
[26], with the exception being during the first vortex step. In place of vortexing for 10 
minutes, the sample in the PowerBead tube was placed into a MP Fast Prep -24™5G 
Sample Preparation System (M.P. Biomedicals LLC, Santa Ana, California) and lysed at 
6.0 m/s for 30 seconds. These steps produced 100 µl of extracted DNA. With DNA was 
extracted, 2 µl tests of each DNA sample were measured in triplicate in a NanoDrop™ 
One (ThermoFisher Scientific, Madison, Wisconsin) to determine the concentration 
(ng/µl) and the quality (A260/A280). The samples were stored at -86 ºC until quantitative 




Figure 1: From Growth to Dilution with Cell Count to DNA Extraction 
Quantitative Amplification  
Quantitative analysis of the extracted DNA samples was performed by qPCR. The 
extracted DNA was serially diluted by five orders of magnitude, ranging from 1:1 to 
1:10,000.  Into each well of a 384-well plate, aliquots of 5 µl Powerup SYBR Green 
Master Mix (Applied Biosystems, A25742, Foster City, California), 1 µl of 100 
nanomole Forward Primer, 1 µl of 100 nanomole Reverse Primer, 2 µl UltraPure™ 
DNase/RNase-Free Distilled Water (Invitrogen, 10977015, Waltham, Massachusetts), 
and 1 µl DNA at dilution was added. For each DNA sample, 15 wells of DNA at dilution 
and 3 wells of negative control were tested. The forward and reverse primers are shown 
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in Table 2. The forward primers, reverse primers, and the qPCR cycling method for B. 
breve [27], L. casei [28], L. rhamnosus GG [29], L. helveticus [30], L. brevis [31], L. 
acidophilus, L. plantarum, L. delbrueckii sub. bulgaricus, and L. paracasei [32] were 
identified from previous studies. Although the researched qPCR methods performed, L. 
delbrueckii sub. bulgaricus and L. brevis required additional cycles to be added for 
complete data.  Each amplification was repeated in triplicate, including the negative 
control, which used DNA/RNA free ultra-purified water instead of sample DNA. The 
384-well plate was sealed and placed into a PlateFuge MicroCentrifuge (Southwest 
Science, C2000, Trenton, New Jersey) for a quick spin to ensure no air bubbles were 
present in the wells. The 384-well plate was placed into a QuantStudio 6 Flex Real-Time 
PCR System (ThermoFisher Scientific, Waltham, Massachusetts) and cycled according to 

























TCA CAC  
ACA AAG 
TGC CTT 
GCT CCC T  
40 cycles:  
Denaturation: 94 °C - 20 sec 
Annealing: 55°C - 20 sec 












35 cycles:  
Denaturation: 95 °C - 20 sec 










40 cycles:  
Denaturation: 94 °C - 1 min 
Annealing: 55°C - 2 min 






 CAG ACT 
GAA AGT 





30 cycles:  
Denaturation: 93 °C - 30 sec 
Annealing: 57°C - 30 sec  
Extension: 72°C - 30 sec 
Final extension: 72°C - 2 min 
[28] 











50 cycles:  
Denaturation: 95 °C - 20 sec 













TCA TA   
35 cycles:  
Denaturation: 94 °C - 45 sec 
Annealing: 58°C - 45 sec 
Extension: 72°C - 1 min 











TTT C  
35 cycles:  
Denaturation: 95 °C - 20 sec 












40 cycles:  
Denaturation: 95 °C - 1 min 
Annealing: 58°C - 30 sec 
Extension: 72°C - 1 min 
Final extension: 72°C - 5 min 
[32] 








40 cycles:  
Denaturation: 95 °C - 15 sec  






Utilizing the data collected from cell counting and the NanoDrop One, three 
samples out of the nine DNA extractions created per species were selected to analyze via 
qPCR based on low variation amongst DNA quality and DNA quantity, higher DNA 
quantity, and DNA quality being close to 1.8. The remaining samples were stored at -86 
ºC to keep for future use. The DNA samples selected from each species, the DNA 
quantity, the DNA quality, and cell counts from the known dilution are in Table 3.  
Standard curves were created, for each species, using the data generated through 
use of the QuantStudio 6 Flex System from each qPCR run.  The quantity of DNA was 
plotted against the cycle threshold (Ct) along a logarithmic scale to create the standard 
curve. An equation for the best fit line as well as the coefficient of determination (R2) 













Table 3: DNA quality, concentration, and cell quantification per species of bacteria  
 
 DNA quantity (ng/µl) DNA quality (A260/A280) Cell Count (cells/ml) 
Species sample  mean stan. dev. mean stan. dev. 
B. breve 2.1 19.63 0.666 1.87 0.006 8.74 X 109 
B. breve 3.1 25.5 0.557 1.76 0.038 8.74 X 109 
B. breve 3.3 20.73 0.231 1.77 0.015 8.04 X 109 
L. acidophilus 1.2 12.77 0.513 1.67 0.04 5.47 X 109 
L. acidophilus 2.2 8.57 0.551 1.81 0.155 5.73 X 109 
L. acidophilus 3.3 18.13 0.379 1.79 0.021 1.05 X 1010 
L. brevis 2.2 21.43 0.808 1.79 0.04 2.43 X 109 
L. brevis 2.3 19.87 0.058 1.79 0.026 2.43 X 109 
L. brevis 3.2 19.83 0.351 1.8 0.06 1.69 X 109 
L. casei 1.1 12.57 0.321 1.82 0.067 3.24 X 109 
L. casei 2.1 9.7 0.3 2 0.023 3.24 X 109 
L. casei 2.2 10.2 0.265 1.82 0.036 3.24 X 109 
L. delbrueckii  
sub. bulgaricus 
1.1 10.67 0.416 1.79 0.106 
8.93 X 109 
L. delbrueckii  
sub. bulgaricus 
2.2 13.73 1.26 1.81 0.006 
9.08 X 109 
L. delbrueckii  
sub. bulgaricus 
3.2 12.67 3.04 1.78 0.047 
9.10 X 109 
L. helveticus 2.1 77.87 0.751 1.81 0.015 3.38 X 109 
L. helveticus 2.2 78.47 0.473 1.83 0.006 3.38 X 109 
L. helveticus 2.3 75.07 0.404 1.84 0.006 3.38 X 109 
L. paracasei 1.3 40.83 0.379 1.8 0.015 1.36 X 1010 
L. paracasei 3.1 32.73 0.306 1.81 0.025 1.08 X 1010 
L. paracasei 3.2 32.77 1.01 1.81 0.023 1.08 X 1010 
L. plantarum 1.2 22.53 0.513 1.85 0.07 8.69 X 109 
L. plantarum 2.2 24.4 0.608 1.78 0.012 9.79 X 109 
L. plantarum 2.3 25.83 1.56 1.81 0.057 9.79 X 109 
L. rhamnosus GG 1.1 35.87 6.62 1.78 0.068 1.73 X 109 
L. rhamnosus GG 1.3 40.1 3.58 1.82 0.031 1.73 X 109 
L. rhamnosus GG 2.2 34.07 6.03 1.77 0.052 1.83 X 109 
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Fig. 4e        Fig. 4f 
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Figure 4a-i: Standard Curves by species with equations  
 
Discussion 
The DNA extraction samples used to create standard curves were selected by the 
DNA quality and DNA quantity. The quality of the DNA extraction is measured as the 
A260/A280 number.  The concentration of nucleic acid in the DNA extraction is 
proportional to the A260 number [33]. The DNA samples were selected for quality close 
to 1.8 [33]. Samples with lower standard deviations in quality were selected over samples 
with higher standard deviations in quality. The DNA quantity was also a factor in 
deciding which of the DNA extraction to use. DNA extractions with DNA quantity 
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higher than 20 ng/µl were preferred [33]. Some of the DNA extractions from the DNA 
tested did not have a quantity over 20 ng/µl, so the extraction chosen for qPCR was based 
off the A260/A280 number and standard deviations.  
The standard curves created will help in the absolute quantification of future 
samples of the tested bacteria. Absolute quantification relies on previously created 
standard curves for the known DNA. The standard curves created from the select bacteria 
species displayed (Figure 4a-i) have equations expressed as Equation 1, with y 
representing the cycle threshold, x representing the quantity, m representing the slop of 
the line, and b representing the y-intercept.  
𝑦 𝑚 log 𝑥 𝑏       (1) 
𝑥 10                        (2) 
Solving for quantity from the Ct, Equation 2, it is possible to take another sample of 
bacterial DNA, quantified by qPCR, and determine the quantity of DNA in the sample 
from these standard curves. Values for equation 2 to determine each standard curve by 
species is listed in Table 4. The reliability of standard curves is determined by the R2 
value, and the efficiency. The R2 value represents how much of the data is captured 
within the equation for the line. The efficiency of the standard curve is how many cycles 
each 10 fold dilution is apart with 100% efficiency being 3.3 cycles [34]. Preferred values 
for efficiency range from 90% to 100% [34]. The equations and values for R2, efficiency, 





Table 4: Variables for the equation: 𝑞𝑢𝑎𝑛𝑡𝑖𝑡𝑦 10 ,  with R2, efficiency, and error 
values to determine standard curves by species 
Species Sample # m b R2 eff % error 
B. breve 2.1 -3.322 10.783 0.998 99.98 0.042 
B. breve 3.1 -3.382 10.710 0.998 97.57 0.047 
B. breve 3.3 -3.233 10.904 0.996 103.9 0.054 
L. acidophilus 1.2 -3.231 11.808 0.997 103.9 0.051 
L. acidophilus 2.2 -3.159 12.711 0.994 107.3 0.071 
L. acidophilus 3.3 -3.284 10.948 0.997 101.6 0.049 
L. brevis 2.2 -3.783 10.421 0.999 83.79 0.040 
L. brevis 2.3 -3.765 10.737 0.999 84.35 0.030 
L. brevis 3.2 -3.814 10.624 0.998 82.88 0.046 
L. casei 1.2 -3.408 13.405 0.988 96.55 0.109 
L. casei 2.2 -3.662 13.346 0.995 87.55 0.077 
L. casei 2.3 -3.586 13.328 0.991 90.05 0.100 
L. delbrueckii  subsp. bulgaricus 1.1 -3.243 26.094 0.988 103.4 0.100 
L. delbrueckii  subsp. bulgaricus 2.2 -3.376 26.216 0.992 97.78 0.085 
L. delbrueckii  subsp. bulgaricus 3.2 -3.277 26.139 0.994 101.9 0.073 
L. helveticus 2.1 -3.556 9.062 0.998 91.07 0.040 
L. helveticus 2.2 -3.459 8.816 0.998 94.57 0.044 
L. helveticus 2.3 -3.522 9.268 0.996 92.29 0.059 
L. paracasei 1.3 -3.175 10.280 0.991 106.5 0.088 
L. paracasei 3.1 -2.951 10.609 0.985 118.2 0.103 
L. paracasei 3.2 -2.858 11.171 0.984 123.8 0.102 
L. plantarum 1.2 -3.35 10.619 0.992 98.83 0.087 
L. plantarum 2.2 -3.391 10.213 0.995 97.18 0.068 
L. plantarum 2.3 -3.233 10.233 0.995 103.8 0.063 
L. rhamnosus GG 1.1 -6.207 11.424 0.969 44.91 0.349 
L. rhamnosus GG 1.3 -3.465 12.197 0.985 94.36 0.163 







The efficiencies of the qPCR results from the DNA extractions are within the 
preferred range with the exception of all samples of L. brevis and one sample of L. 
rhamnosus GG. This could be due to the sample containing PCR inhibitors or incorrect 
primer design [34]. The data created from all samples of L. brevis could be used as 
reference, but should be reaccomplished to for better efficiency values. Sample 1.1 of L. 
rhamnosus GG should be discarded, but was included for consistency in data displayed. 
Conclusion 
The assays created can be used in the holistic treatment of mental and physical 
health afflictions. Specifically, following the methods above, samples can be extracted to 
determine cell counts of specific microorganism from a subject to determine the 
abundance of each microorganism and to assist in multiple areas of study into these 
microorganisms. Some of these areas of research include the addition of probiotics 
alongside pharmaceutical prescriptions [2], continued research into the gut-brain axis 
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Chapter 4: qPCR Data Sheets for Immunomodulatory Bacteria 
Chapter Overview: 
This chapter provides the product created from research in Chapter 2 and the 
results from chapter 3. Details are illustrated for the all data required to replicate the 
qPCR assays of the nine species of bacteria in the genera of Lactobacillus and 
Bifidobacterium.  The quantitative amplification of the DNA is illustrated as well as the 
methods required to replicate the qPCR. Amplification curve plots, melt curve plots, and 
standard curve plots, with equations, were compiled as well as all methods and materials. 
The end product of all the research and experimentation are theses data sheets.  Future 
research and application of gut microorganisms could benefit from the sheets in this 
chapter. 
Publication Intention: 
Title: qPCR Data Sheets for Immunomodulatory Bacteria  














































Chapter 5: Conclusions and Recommendations 
Conclusions of Research 
There is a significant connection between the gut microbiome and effects on 
mental and physical health.  Future research into the gut brain axis will require an 
established method to identify and quantify the microorganisms which occupy the human 
gut. The objectives of this thesis were to: 
1) Identify microorganisms associated to be beneficial to human mental and 
physical health. 
2) Develop methods by which to grow, quantify cells, and extract DNA of the 
beneficial microorganisms as well as primers and methods to create qPCR 
assays. 
3) Compile a reference guide containing all methods, materials, melt curves, 
amplification curves, and standard curves for each of the microorganisms 
chosen. 
In the review of multiple microorganisms, many were identified as beneficial to 
mental and physical health (Chapter 2, Table 1). These microorganisms exist on food 
naturally or can be added to control the fermentation process. Evidence from multiple 
studies demonstrate the possible health benefits humans could garner from these 
microorganisms. Although some of the studies confine their research to in-vitro and 
animal studies, there is a benefit to studying effects on human. Symptoms associated with 
depression, anxiety, and systemic inflammations are some of the overlapping conditions 
which were found to be treated by microorganisms. The microorganisms selected for 
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qPCR are only a small portion in the total community of beneficial microorganisms 
discovered in research. The selected microorganisms complete the first objective. Chapter 
3 ties the selected microorganisms to objective two. The methods and materials outlined 
in Chapter 3 led to the successful creation of nine qPCR assays. Using information found 
within other studies into qPCR assays, the methods to produce successful and reliable 
amplifications and standard curves were compiled and verified. The final objective was 
met with the creation of a reference guide, Chapter 4, which can be used for future 
research and studies utilizing these nine bacteria species. 
Significance of Research 
The benefits that could be garnered from this thesis is the addition of probiotic 
bacteria to the treatment of depression, anxiety, and systemic inflammation. Health 
professionals could test a patient’s gut microbiome to determine if there are specific 
bacterial species missing. Prescribing a probiotic of missing bacterial species could 
alleviate the symptoms which accompany the condition for which they are being treated. 
Additional areas of research that could benefit from the create standard curves include the 
addition of probiotics alongside pharmaceutical prescriptions [1], continued research into 
the gut-brain axis [2]-[4], or furthering studies into the probiotic properties of fermented 
foods [5], [6].  
Recommendations for Future Research 
The selected bacterial species are only a small percentage of the microorganisms 
which could affect mental and physical health. Only nine species of the seventeen 
identified in Chapter 2 were used to create information in the reference guide.  The 
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additional eight plus multitudes of others that have shown some connection to benefit 
health could be added to the reference guide, with continued additions until all known 
microorganisms associated with human health are covered. Additional qPCR assays, 
methods, materials, procedures, and the data collected will be required to create a 
complete guide for future research and utilization. A complete reference guide would 
provide additional tools for health professionals, food scientists, and Department of 
Defense researchers to assist in finding new ways to apply the benefits these 
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Experiment Name: 2020-01-07 112415 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_B_breve_20200107_standard curve.eds 
Run Started:  01-07-2020 17:09:59 PST 
Run Finished:  01-07-2020 19:11:28 PST 
Run Duration:  121 minutes 29 seconds 
Date Modified:  01-07-2020 14:09:51 PST 
Date Created: 
User: 
01-07-2020 11:24:15 PST 
Number of Wells Used: 54 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 3 
Comments: 
















For Research Use Only. Not for use in diagnostic procedures. 












Blank B. breve 
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Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-3.3116 Y-Intercept:10.654 R²:0.996 Eff%:100.433 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 
























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
B2 Sample 2.1 B. breve S 1.000 10.937 11.017 0.185 89.344 
B3 Sample 2.1 B. breve S 1.000 10.884 11.017 0.185 89.344 
B4 Sample 2.1 B. breve S 1.000 11.229 11.017 0.185 89.344 
B5 Sample 2.1 B. breve S 0.100 14.098 13.922 0.194 89.344 
B6 Sample 2.1 B. breve S 0.100 13.714 13.922 0.194 89.344 
B7 Sample 2.1 B. breve S 0.100 13.955 13.922 0.194 89.344 
B8 Sample 2.1 B. breve S 0.010 17.089 17.187 0.131 89.344 
B9 Sample 2.1 B. breve S 0.010 17.336 17.187 0.131 89.344 
B10 Sample 2.1 B. breve S 0.010 17.137 17.187 0.131 89.344 
B11 Sample 2.1 B. breve S 0.001 20.873 20.851 0.039 89.344 
B12 Sample 2.1 B. breve S 0.001 20.806 20.851 0.039 89.344 
B13 Sample 2.1 B. breve S 0.001 20.874 20.851 0.039 89.344 
B14 Sample 2.1 B. breve S 0.000 24.236 24.165 0.099 89.344 
B15 Sample 2.1 B. breve S 0.000 24.051 24.165 0.099 89.344 
B16 Sample 2.1 B. breve S 0.000 24.208 24.165 0.099 89.344 
B17 Blank B. breve N  UND.   61.386 
B18 Blank B. breve N  UND.   61.386 
B19 Blank B. breve N  UND.   61.386 
D2 Sample 3.1 B. breve S 1.000 10.450 10.601 0.188 89.344 
D3 Sample 3.1 B. breve S 1.000 10.812 10.601 0.188 89.476 
D4 Sample 3.1 B. breve S 1.000 10.541 10.601 0.188 89.344 
D5 Sample 3.1 B. breve S 0.100 13.863 13.804 0.219 89.344 
D6 Sample 3.1 B. breve S 0.100 13.561 13.804 0.219 89.344 
D7 Sample 3.1 B. breve S 0.100 13.986 13.804 0.219 89.344 
D8 Sample 3.1 B. breve S 0.010 16.975 16.846 0.136 89.344 
D9 Sample 3.1 B. breve S 0.010 16.704 16.846 0.136 89.344 
D10 Sample 3.1 B. breve S 0.010 16.859 16.846 0.136 89.344 
D11 Sample 3.1 B. breve S 0.001 20.917 20.820 0.121 89.344 
D12 Sample 3.1 B. breve S 0.001 20.685 20.820 0.121 89.344 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 




























D13 Sample 3.1 B. breve S 0.001 20.859 20.820 0.121 89.344  
D14 Sample 3.1 B. breve S 0.000 24.011 24.002 0.017 89.344  
D15 Sample 3.1 B. breve S 0.000 24.012 24.002 0.017 89.344  
D16 Sample 3.1 B. breve S 0.000 23.982 24.002 0.017 89.344  
D17 Blank B. breve N  UND.   61.518 89.212 
D18 Blank B. breve N  UND.   61.386  
D19 Blank B. breve N  UND.   61.386  
F2 Sample 3.3 B. breve S 1.000 10.801 10.872 0.091 89.344  
F3 Sample 3.3 B. breve S 1.000 10.974 10.872 0.091 89.344  
F4 Sample 3.3 B. breve S 1.000 10.839 10.872 0.091 89.344  
F5 Sample 3.3 B. breve S 0.100 14.239 14.117 0.111 89.344  
F6 Sample 3.3 B. breve S 0.100 14.089 14.117 0.111 89.344  
F7 Sample 3.3 B. breve S 0.100 14.023 14.117 0.111 89.344  
F8 Sample 3.3 B. breve S 0.010 16.735 16.761 0.056 89.344  
F9 Sample 3.3 B. breve S 0.010 16.723 16.761 0.056 89.344  
F10 Sample 3.3 B. breve S 0.010 16.826 16.761 0.056 89.344  
F11 Sample 3.3 B. breve S 0.001 20.178 20.225 0.052 89.344  
F12 Sample 3.3 B. breve S 0.001 20.216 20.225 0.052 89.344  
F13 Sample 3.3 B. breve S 0.001 20.281 20.225 0.052 89.344  
F14 Sample 3.3 B. breve S 0.000 23.900 23.970 0.062 89.344  
F15 Sample 3.3 B. breve S 0.000 24.020 23.970 0.062 89.344  
F16 Sample 3.3 B. breve S 0.000 23.990 23.970 0.062 89.212  
F17 Blank B. breve N  UND.   61.386  
F18 Blank B. breve N  UND.   61.386  
F19 Blank B. breve N  UND.   61.386  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 1 
Well Setup 54 Flagged Wells 0 Samples Used 4 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 0  
HIGHSD High standard deviation in 
replicate group 
0  
NOAMP No amplification 0  
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 0  
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 40 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 1.6 DEGREES_ 60.0 60 0.0 0 




















































































Customer is responsible for any validation of assays and compliance with regulatory requirements that pertain to 
their procedures and uses of reagents and/or instruments. 
© 2015 Thermo Fisher Scientific. All rights reserved. The trademarks mentioned herein are the property of Thermo 





















Experiment Name: 2020-01-03 123815 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_L_acidophilus_20200103_standardcurve1.eds 
Run Started:  01-03-2020 17:51:40 PST 
Run Finished:  01-03-2020 20:13:06 PST 
Run Duration:  141 minutes 26 seconds 
Date Modified:  01-03-2020 15:35:25 PST 
Date Created: 
User: 
01-03-2020 12:38:15 PST 
Number of Wells Used: 54 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 2 
Comments:  L. acidophilus 
















For Research Use Only. Not for use in diagnostic procedures. 
































Lactobacillus acidophilus   
  0.000 30.249 
blank Lactobacillus acidophilus 
  





















Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-3.2232 Y-Intercept:11.6732 R²:0.984 Eff%:104.292 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 
























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
  Lactobacillu       
B2 Sample 1.2 s S 1.000 12.096 11.906 0.176 77.989 
  acidophilus       
  Lactobacillu       
B3 Sample 1.2 s S 1.000 11.749 11.906 0.176 77.989 
  acidophilus       
  Lactobacillu       
B4 Sample 1.2 s S 1.000 11.873 11.906 0.176 77.989 
  acidophilus       
  Lactobacillu       
B5 Sample 1.2 s S 0.100 14.895 14.727 0.201 77.858 
  acidophilus       
  Lactobacillu       
B6 Sample 1.2 s S 0.100 14.783 14.727 0.201 77.858 
  acidophilus       
  Lactobacillu       
B7 Sample 1.2 s S 0.100 14.504 14.727 0.201 77.858 
  acidophilus       
  Lactobacillu       
B8 Sample 1.2 s S 0.010 17.695 17.739 0.050 77.726 
  acidophilus       
  Lactobacillu       
B9 Sample 1.2 s S 0.010 17.729 17.739 0.050 77.726 
  acidophilus       
  Lactobacillu       
B10 Sample 1.2 s S 0.010 17.793 17.739 0.050 77.726 
  acidophilus       
  Lactobacillu       
B11 Sample 1.2 s S 0.001 21.313 21.483 0.214 77.726 
  acidophilus       
  Lactobacillu       
B12 Sample 1.2 s S 0.001 21.724 21.483 0.214 77.726 
  acidophilus       
  Lactobacillu       
B13 Sample 1.2 s S 0.001 21.413 21.483 0.214 77.726 
  acidophilus       
  Lactobacillu       
B14 Sample 1.2 s S 0.000 24.753 24.668 0.098 77.594 
  acidophilus       
  Lactobacillu       
B15 Sample 1.2 s S 0.000 24.561 24.668 0.098 77.594 
  acidophilus       
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 


























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
  Lactobacillu        
B16 Sample 1.2 s S 0.000 24.691 24.668 0.098  77.594 
  acidophilus        
  Lactobacillu        
B17 blank s U  UND. 30.249  0.000 61.648 
  acidophilus        
  Lactobacillu        
B18 blank s U  UND. 30.249  0.000 61.516 
  acidophilus        
  Lactobacillu        
B19 blank s U  UND. 30.249  0.000 61.516 
  acidophilus        
  Lactobacillu        
D2 Sample 2.2 s S 1.000 12.564 12.577 0.195  77.989 
  acidophilus        
  Lactobacillu        
D3 Sample 2.2 s S 1.000 12.388 12.577 0.195  77.989 
  acidophilus        
  Lactobacillu        
D4 Sample 2.2 s S 1.000 12.778 12.577 0.195  77.858 
  acidophilus        
  Lactobacillu        
D5 Sample 2.2 s S 0.100 15.623 15.636 0.050  77.858 
  acidophilus        
  Lactobacillu        
D6 Sample 2.2 s S 0.100 15.692 15.636 0.050  77.858 
  acidophilus        
  Lactobacillu        
D7 Sample 2.2 s S 0.100 15.594 15.636 0.050  77.858 
  acidophilus        
  Lactobacillu        
D8 Sample 2.2 s S 0.010 18.249 18.355 0.127  77.726 
  acidophilus        
  Lactobacillu        
D9 Sample 2.2 s S 0.010 18.495 18.355 0.127  77.726 
  acidophilus        
  Lactobacillu        
D10 Sample 2.2 s S 0.010 18.321 18.355 0.127  77.726 
  acidophilus        
  Lactobacillu        
D11 Sample 2.2 s S 0.001 22.132 21.878 0.744  77.594 
  acidophilus        
  Lactobacillu        
D12 Sample 2.2 s S 0.001 22.463 21.878 0.744  77.594 
  acidophilus        
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 


























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
  Lactobacillu        
D13 Sample 2.2 s S 0.001 21.041 21.878 0.744  77.726 
  acidophilus        
  Lactobacillu        
D14 Sample 2.2 s S 0.000 25.375 25.245 0.248  77.594 
  acidophilus        
  Lactobacillu        
D15 Sample 2.2 s S 0.000 24.958 25.245 0.248  77.462 
  acidophilus        
  Lactobacillu        
D16 Sample 2.2 s S 0.000 25.400 25.245 0.248  77.462 
  acidophilus        
  Lactobacillu        
D17 blank s U 0.000 30.249 30.249  0.000 77.199 
  acidophilus        
  Lactobacillu        
D18 blank s U  UND. 30.249  0.000 61.516 
  acidophilus        
  Lactobacillu        
D19 blank s U  UND. 30.249  0.000 75.617 
  acidophilus        
  Lactobacillu        
F2 Sample 3.3 s S 1.000 11.151 11.126 0.071  77.989 
  acidophilus        
  Lactobacillu        
F3 Sample 3.3 s S 1.000 11.180 11.126 0.071  77.989 
  acidophilus        
  Lactobacillu        
F4 Sample 3.3 s S 1.000 11.045 11.126 0.071  77.989 
  acidophilus        
  Lactobacillu        
F5 Sample 3.3 s S 0.100 14.044 14.041 0.129  77.858 
  acidophilus        
  Lactobacillu        
F6 Sample 3.3 s S 0.100 13.910 14.041 0.129  77.858 
  acidophilus        
  Lactobacillu        
F7 Sample 3.3 s S 0.100 14.168 14.041 0.129  77.858 
  acidophilus        
  Lactobacillu        
F8 Sample 3.3 s S 0.010 17.162 17.275 0.147  77.858 
  acidophilus        
  Lactobacillu        
F9 Sample 3.3 s S 0.010 17.441 17.275 0.147  77.726 
  acidophilus        
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 


























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
  Lactobacillu        
F10 Sample 3.3 s S 0.010 17.221 17.275 0.147  77.858 
  acidophilus        
  Lactobacillu        
F11 Sample 3.3 s S 0.001 21.328 21.148 0.177  77.726 
  acidophilus        
  Lactobacillu        
F12 Sample 3.3 s S 0.001 21.142 21.148 0.177  77.726 
  acidophilus        
  Lactobacillu        
F13 Sample 3.3 s S 0.001 20.973 21.148 0.177  77.726 
  acidophilus        
  Lactobacillu        
F14 Sample 3.3 s S 0.000 24.034 23.992 0.037  77.594 
  acidophilus        
  Lactobacillu        
F15 Sample 3.3 s S 0.000 23.980 23.992 0.037  77.594 
  acidophilus        
  Lactobacillu        
F16 Sample 3.3 s S 0.000 23.962 23.992 0.037  77.594 
  acidophilus        
  Lactobacillu        
F17 blank s U  UND. 30.249  0.000 76.803 
  acidophilus        
  Lactobacillu        
F18 blank s U  UND. 30.249  0.000 61.384 
  acidophilus        
  Lactobacillu        
F19 blank s U  UND. 30.249  0.000 61.648 
  acidophilus        
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 1 
Well Setup 54 Flagged Wells 9 Samples Used 4 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 6 B17, B18, B19, D18, F18, F19 
HIGHSD High standard deviation in 
replicate group 
3 D11, D12, D13 
NOAMP No amplification 5 B18, B19, D18, F18, F19 
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 0  
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 35 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 0.05 DEGREES_ 95.0 15 0.0 0 





























































Customer is responsible for any validation of assays and compliance with regulatory requirements that pertain to 
their procedures and uses of reagents and/or instruments. 
© 2015 Thermo Fisher Scientific. All rights reserved. The trademarks mentioned herein are the property of Thermo 





















Experiment Name: 2020-01-10 143244 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_LBrevis_01102020_StandardCurve.eds 
Run Started:  01-10-2020 21:03:18 PST 
Run Finished:  01-11-2020 02:22:51 PST 
Run Duration:  319 minutes 32 seconds 
Date Modified:  01-10-2020 21:21:06 PST 
Date Created: 
User: 
01-10-2020 14:32:44 PST 
Number of Wells Used: 72 
Number of Wells with Results: 72 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 3 
Comments: 
















For Research Use Only. Not for use in diagnostic procedures. 
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L. brevis   





















Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-3.4378 Y-Intercept:11.4365 R²:0.765 Eff%:95.382 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 





























B2 1.1 L. brevis S 1.000 11.375 11.191 0.161 85.615  
B3 1.1 L. brevis S 1.000 11.127 11.191 0.161 85.615  
B4 1.1 L. brevis S 1.000 11.073 11.191 0.161 85.483  
B5 1.1 L. brevis S 0.100 14.762 14.552 0.308 85.483  
B6 1.1 L. brevis S 0.100 14.199 14.552 0.308 85.483  
B7 1.1 L. brevis S 0.100 14.696 14.552 0.308 85.483  
B8 1.1 L. brevis S 0.010 18.421 18.457 0.332 85.483  
B9 1.1 L. brevis S 0.010 18.145 18.457 0.332 85.483  
B10 1.1 L. brevis S 0.010 18.805 18.457 0.332 85.615  
B11 1.1 L. brevis S 0.001 22.914 22.540 0.324 85.615  
B12 1.1 L. brevis S 0.001 22.343 22.540 0.324 85.615  
B13 1.1 L. brevis S 0.001 22.364 22.540 0.324 85.615  
B14 1.1 L. brevis S 0.000 25.985 26.415 0.402 85.615  
B15 1.1 L. brevis S 0.000 26.780 26.415 0.402 85.615  
B16 1.1 L. brevis S 0.000 26.480 26.415 0.402 85.615  
B17 Blank L. brevis N  UND.   61.385 84.825 
B18 Blank L. brevis N  UND.   61.254 89.960 
B19 Blank L. brevis N  UND.   61.385  
D2 2.2 L. brevis S 1.000 9.993 17.149 12.306 85.483  
D3 2.2 L. brevis S 1.000 10.096 17.149 12.306 85.483  
D4 2.2 L. brevis S 1.000 31.359 17.149 12.306 85.615  
D5 2.2 L. brevis S 0.100 13.782 13.841 0.200 85.483  
D6 2.2 L. brevis S 0.100 13.677 13.841 0.200 85.483  
D7 2.2 L. brevis S 0.100 14.064 13.841 0.200 85.483  
D8 2.2 L. brevis S 0.010 17.550 17.521 0.048 85.483  
D9 2.2 L. brevis S 0.010 17.466 17.521 0.048 85.483  
D10 2.2 L. brevis S 0.010 17.547 17.521 0.048 85.483  
D11 2.2 L. brevis S 0.001 21.367 21.156 0.194 85.483  
D12 2.2 L. brevis S 0.001 20.985 21.156 0.194 85.483  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 




























D13 2.2 L. brevis S 0.001 21.115 21.156 0.194 85.483  
D14 2.2 L. brevis S 0.000 25.480 25.272 0.225 85.483  
D15 2.2 L. brevis S 0.000 25.034 25.272 0.225 85.483  
D16 2.2 L. brevis S 0.000 25.301 25.272 0.225 85.483  
D17 Blank L. brevis N  UND.   61.385  
D18 Blank L. brevis N  UND.   61.385  
D19 Blank L. brevis N  UND.   61.254  
F2 2.3 L. brevis S 1.000 10.281 10.364 0.087 85.615  
F3 2.3 L. brevis S 1.000 10.358 10.364 0.087 85.615  
F4 2.3 L. brevis S 1.000 10.454 10.364 0.087 85.615  
F5 2.3 L. brevis S 0.100 13.935 13.918 0.027 85.483  
F6 2.3 L. brevis S 0.100 13.887 13.918 0.027 85.483  
F7 2.3 L. brevis S 0.100 13.932 13.918 0.027 85.483  
F8 2.3 L. brevis S 0.010 17.803 17.891 0.157 85.483  
F9 2.3 L. brevis S 0.010 18.072 17.891 0.157 85.483  
F10 2.3 L. brevis S 0.010 17.798 17.891 0.157 85.615  
F11 2.3 L. brevis S 0.001 21.631 21.586 0.061 85.615  
F12 2.3 L. brevis S 0.001 21.610 21.586 0.061 85.615  
F13 2.3 L. brevis S 0.001 21.517 21.586 0.061 85.483  
F14 2.3 L. brevis S 0.000 25.606 25.360 0.271 85.483  
F15 2.3 L. brevis S 0.000 25.069 25.360 0.271 85.483  
F16 2.3 L. brevis S 0.000 25.404 25.360 0.271 85.483  
F17 Blank L. brevis N  UND.   61.385 85.220 
F18 Blank L. brevis N  UND.   61.385  
F19 Blank L. brevis N  UND.   61.517 84.956 
H2 3.2 L. brevis S 1.000 10.162 10.191 0.188 85.615  
H3 3.2 L. brevis S 1.000 10.391 10.191 0.188 85.615  
H4 3.2 L. brevis S 1.000 10.019 10.191 0.188 85.615  
H5 3.2 L. brevis S 0.100 UND. 13.805 0.043 62.044  
H6 3.2 L. brevis S 0.100 13.775 13.805 0.043 85.483  
H7 3.2 L. brevis S 0.100 13.835 13.805 0.043 85.483  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 




























H8 3.2 L. brevis S 0.010 17.983 17.748 0.238 85.615  
H9 3.2 L. brevis S 0.010 17.508 17.748 0.238 85.615  
H10 3.2 L. brevis S 0.010 17.754 17.748 0.238 85.615  
H11 3.2 L. brevis S 0.001 21.651 21.457 0.216 85.615  
H12 3.2 L. brevis S 0.001 21.225 21.457 0.216 85.615  
H13 3.2 L. brevis S 0.001 21.494 21.457 0.216 85.615  
H14 3.2 L. brevis S 0.000 25.447 25.473 0.392 85.615  
H15 3.2 L. brevis S 0.000 25.095 25.473 0.392 85.483  
H16 3.2 L. brevis S 0.000 25.877 25.473 0.392 85.615  
H17 Blank L. brevis N  UND.   61.385 85.220 
H18 Blank L. brevis N  UND.   61.385 91.145 
H19 Blank L. brevis N  UND.   61.517  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 72 Targets Used 1 
Well Setup 72 Flagged Wells 4 Samples Used 5 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 1 H5 
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 1 H5 
HIGHSD High standard deviation in 
replicate group 
3 D2, D3, D4 
NOAMP No amplification 0  
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 1 D4 
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 50 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 1.6 DEGREES_ 60.0 60 0.0 0 




















































































Customer is responsible for any validation of assays and compliance with regulatory requirements that pertain to 
their procedures and uses of reagents and/or instruments. 
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Experiment Name: 2020-01-13 103751 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_L_casei_20200113_standardcurve2.eds 
Run Started:  01-13-2020 20:42:55 PST 
Run Finished:  01-13-2020 22:44:01 PST 
Run Duration:  121 minutes 6 seconds 
Date Modified:  01-13-2020 17:42:07 PST 
Date Created: 
User: 
01-13-2020 10:37:50 PST 
Number of Wells Used: 54 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 3 
Comments: 
















For Research Use Only. Not for use in diagnostic procedures. 












Blank L. casei 
Sample 1.2 L. casei 
Sample 2.2 L. casei 
Sample 2.3 L. casei 
 
Results Summary 





(Std Dev) (Mean) (Std Dev) 











































slope:-3.5908 Y-Intercept:13.2401 R²:0.979 Eff%:89.884 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 





























B2 Sample 1.2 L. casei S 1.000 12.999 13.624 0.848 85.798  
B3 Sample 1.2 L. casei S 1.000 14.589 13.624 0.848 85.798  
B4 Sample 1.2 L. casei S 1.000 13.283 13.624 0.848 85.798  
B5 Sample 1.2 L. casei S 0.100 16.139 16.387 0.249 85.798  
B6 Sample 1.2 L. casei S 0.100 16.638 16.387 0.249 85.798  
B7 Sample 1.2 L. casei S 0.100 16.383 16.387 0.249 85.798  
B8 Sample 1.2 L. casei S 0.010 20.313 19.777 0.480 85.798  
B9 Sample 1.2 L. casei S 0.010 19.630 19.777 0.480 85.798  
B10 Sample 1.2 L. casei S 0.010 19.388 19.777 0.480 85.798  
B11 Sample 1.2 L. casei S 0.001 23.109 24.936 2.239 85.798  
B12 Sample 1.2 L. casei S 0.001 27.434 24.936 2.239 85.798  
B13 Sample 1.2 L. casei S 0.001 24.266 24.936 2.239 85.798  
B14 Sample 1.2 L. casei S 0.000 27.027 27.048 0.357 85.798  
B15 Sample 1.2 L. casei S 0.000 27.414 27.048 0.357 85.798  
B16 Sample 1.2 L. casei S 0.000 26.701 27.048 0.357 85.666  
B17 Blank L. casei N  UND.   61.411 85.139 
B18 Blank L. casei N  UND.   61.411  
B19 Blank L. casei N  UND.   61.279  
D2 Sample 2.2 L. casei S 1.000 UND. 13.241 0.294 61.411 85.402 
D3 Sample 2.2 L. casei S 1.000 13.033 13.241 0.294 85.798  
D4 Sample 2.2 L. casei S 1.000 13.449 13.241 0.294 85.798  
D5 Sample 2.2 L. casei S 0.100 16.239 16.308 0.212 85.666  
D6 Sample 2.2 L. casei S 0.100 16.140 16.308 0.212 85.666  
D7 Sample 2.2 L. casei S 0.100 16.547 16.308 0.212 85.798  
D8 Sample 2.2 L. casei S 0.010 20.493 20.812 0.279 85.798  
D9 Sample 2.2 L. casei S 0.010 21.011 20.812 0.279 85.798  
D10 Sample 2.2 L. casei S 0.010 20.932 20.812 0.279 85.798  
D11 Sample 2.2 L. casei S 0.001 24.375 24.152 0.301 85.798  
D12 Sample 2.2 L. casei S 0.001 24.272 24.152 0.301 85.798  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 




























D13 Sample 2.2 L. casei S 0.001 23.809 24.152 0.301 85.798  
D14 Sample 2.2 L. casei S 0.000 27.742 27.565 0.157 85.798  
D15 Sample 2.2 L. casei S 0.000 27.444 27.565 0.157 85.666  
D16 Sample 2.2 L. casei S 0.000 27.509 27.565 0.157 85.666  
D17 Blank L. casei N  UND.   61.411 85.271 
D18 Blank L. casei N  UND.   61.411  
D19 Blank L. casei N  UND.   61.411  
F2 Sample 2.3 L. casei S 1.000 13.412 13.639 0.197 85.798  
F3 Sample 2.3 L. casei S 1.000 13.768 13.639 0.197 85.798  
F4 Sample 2.3 L. casei S 1.000 13.736 13.639 0.197 85.798  
F5 Sample 2.3 L. casei S 0.100 16.536 16.622 0.303 85.798  
F6 Sample 2.3 L. casei S 0.100 16.371 16.622 0.303 85.798  
F7 Sample 2.3 L. casei S 0.100 16.959 16.622 0.303 85.798  
F8 Sample 2.3 L. casei S 0.010 20.146 20.169 0.127 85.798  
F9 Sample 2.3 L. casei S 0.010 20.055 20.169 0.127 85.798  
F10 Sample 2.3 L. casei S 0.010 20.306 20.169 0.127 85.798  
F11 Sample 2.3 L. casei S 0.001 25.262 24.535 1.029 85.798  
F12 Sample 2.3 L. casei S 0.001 UND. 24.535 1.029 86.852  
F13 Sample 2.3 L. casei S 0.001 23.807 24.535 1.029 85.798  
F14 Sample 2.3 L. casei S 0.000 27.052 27.687 0.651 85.666  
F15 Sample 2.3 L. casei S 0.000 27.655 27.687 0.651 85.666  
F16 Sample 2.3 L. casei S 0.000 28.353 27.687 0.651 85.666  
F17 Blank L. casei N  UND.   61.279 85.534 
F18 Blank L. casei N  UND.   61.279  
F19 Blank L. casei N  UND.   61.411  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 1 
Well Setup 54 Flagged Wells 13 Samples Used 4 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 2 D2, F12 
HIGHSD High standard deviation in 
replicate group 
11 B2, B3, B4, B11, B12, B13, F11, F13, F14, 
F15, F16 
NOAMP No amplification 0  
NOISE Noise higher than others in plate 1 F12 
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 0  
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 1 F12 
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 40 1 false 
Hold Stage 1 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 1.6 DEGREES_ 95.0 15 0.0 0 
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Experiment Name: 2020-01-10 100938 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_L_delbruki_B_bifidum_20200110_standardcurve.eds 
Run Started:  01-10-2020 16:34:47 PST 
Run Finished:  01-10-2020 20:16:00 PST 
Run Duration:  221 minutes 12 seconds 
Date Modified:  01-10-2020 15:14:17 PST 
Date Created: 
User: 
01-10-2020 10:09:38 PST 
Number of Wells Used: 108 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 2 
Comments: 
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THIS FILE 
 
For Research Use Only. Not for use in diagnostic procedures. 














Sample Target Quantity Quantity                             
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Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-3.2993 Y-Intercept:26.1218 R²:0.99 Eff%:100.953 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 
























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
B2 
Sample L1. 
L. delbruki S 1.000 25.994 26.249 0.548 76.007 
 1        
B3 
Sample L1. 
L. delbruki S 1.000 25.875 26.249 0.548 76.007 
 1        
B4 
Sample L1. 
L. delbruki S 1.000 26.878 26.249 0.548 75.875 
 1        
B5 
Sample L1. 
L. delbruki S 0.100 29.114 29.082 0.074 76.007 
 1        
B6 
Sample L1. 
L. delbruki S 0.100 29.135 29.082 0.074 76.007 
 1        
B7 
Sample L1. 
L. delbruki S 0.100 28.997 29.082 0.074 75.875 
 1        
B8 
Sample L1. 
L. delbruki S 0.010 32.372 32.402 0.177 75.875 
 1        
B9 
Sample L1. 
L. delbruki S 0.010 32.242 32.402 0.177 75.875 
 1        
B10 
Sample L1. 
L. delbruki S 0.010 32.591 32.402 0.177 76.007 
 1        
B11 
Sample L1. 
L. delbruki S 0.001 36.110 36.029 0.163 75.875 
 1        
B12 
Sample L1. 
L. delbruki S 0.001 36.135 36.029 0.163 75.875 
 1        
B13 
Sample L1. 
L. delbruki S 0.001 35.841 36.029 0.163 75.875 
 1        
B14 
Sample L1. 
L. delbruki S 0.000 38.225 38.985 1.154 75.875 
 1        
B15 
Sample L1. 
L. delbruki S 0.000 40.313 38.985 1.154 75.743 
 1        
B16 
Sample L1. 
L. delbruki S 0.000 38.417 38.985 1.154 75.875 
 1        
B17 Blank L. delbruki N  UND.   61.517 
B18 Blank L. delbruki N  UND.   75.480 
B19 Blank L. delbruki N  UND.   61.385 
D2 
Sample L2. 
L. delbruki S 1.000 26.391 26.423 0.141 76.007 
 2        
D3 
Sample L2. 
L. delbruki S 1.000 26.300 26.423 0.141 76.007 
 2        
D4 
Sample L2. 
L. delbruki S 1.000 26.577 26.423 0.141 76.007 
 2        
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
D5 
Sample L2. 
L. delbruki S 0.100 29.496 29.571 0.093 76.007 
 2        
D6 
Sample L2. 
L. delbruki S 0.100 29.543 29.571 0.093 76.138 
 2        
D7 
Sample L2. 
L. delbruki S 0.100 29.675 29.571 0.093 75.875 
 2        
D8 
Sample L2. 
L. delbruki S 0.010 32.577 32.520 0.094 75.875 
 2        
D9 
Sample L2. 
L. delbruki S 0.010 32.572 32.520 0.094 75.875 
 2        
D10 
Sample L2. 
L. delbruki S 0.010 32.412 32.520 0.094 75.875 
 2        
D11 
Sample L2. 
L. delbruki S 0.001 36.106 35.955 0.156 75.875 
 2        
D12 
Sample L2. 
L. delbruki S 0.001 35.793 35.955 0.156 75.875 
 2        
D13 
Sample L2. 
L. delbruki S 0.001 35.965 35.955 0.156 75.875 
 2        
D14 
Sample L2. 
L. delbruki S 0.000 40.961 40.129 0.744 75.743 
 2        
D15 
Sample L2. 
L. delbruki S 0.000 39.896 40.129 0.744 75.875 
 2        
D16 
Sample L2. 
L. delbruki S 0.000 39.529 40.129 0.744 76.007 
 2        
D17 Blank L. delbruki N  UND.   75.480 
D18 Blank L. delbruki N  52.850   76.533 
D19 Blank L. delbruki N  54.993   76.138 
F2 
Sample L3. 
L. delbruki S 1.000 26.088 26.160 0.072 76.007 
 2        
F3 
Sample L3. 
L. delbruki S 1.000 26.232 26.160 0.072 76.007 
 2        
F4 
Sample L3. 
L. delbruki S 1.000 26.160 26.160 0.072 76.007 
 2        
F5 
Sample L3. 
L. delbruki S 0.100 29.131 29.474 0.314 76.007 
 2        
F6 
Sample L3. 
L. delbruki S 0.100 29.749 29.474 0.314 76.007 
 2        
F7 
Sample L3. 
L. delbruki S 0.100 29.542 29.474 0.314 76.007 
 2        
F8 
Sample L3. 
L. delbruki S 0.010 32.304 32.555 0.350 75.875 
 2        
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
F9 
Sample L3. 
L. delbruki S 0.010 32.406 32.555 0.350 75.875 
 2        
F10 
Sample L3. 
L. delbruki S 0.010 32.955 32.555 0.350 75.875 
 2        
F11 
Sample L3. 
L. delbruki S 0.001 36.341 35.990 0.813 75.875 
 2        
F12 
Sample L3. 
L. delbruki S 0.001 36.569 35.990 0.813 75.875 
 2        
F13 
Sample L3. 
L. delbruki S 0.001 35.061 35.990 0.813 75.875 
 2        
F14 
Sample L3. 
L. delbruki S 0.000 39.132 39.285 0.320 75.611 
 2        
F15 
Sample L3. 
L. delbruki S 0.000 39.071 39.285 0.320 75.480 
 2        
F16 
Sample L3. 
L. delbruki S 0.000 39.653 39.285 0.320 75.875 
 2        
F17 Blank L. delbruki N  UND.   61.385 
F18 Blank L. delbruki N  38.644   76.402 
F19 Blank L. delbruki N  UND.   75.480 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 2 
Well Setup 108 Flagged Wells 12 Samples Used 7 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 0  
HIGHSD High standard deviation in 
replicate group 
12 B2, B3, B4, B14, B15, B16, D14, D15, D16, 
F11, F12, F13 
NOAMP No amplification 0  
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 0  
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 60 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 0.05 DEGREES_ 95.0 15 0.0 0 
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Experiment Name: 2020-01-03 151049 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_L_helveticus_20200103_standardcurve.eds 
Run Started:  01-03-2020 20:21:31 PST 
Run Finished:  01-03-2020 22:51:05 PST 
Run Duration:  149 minutes 33 seconds 
Date Modified:  01-03-2020 17:49:39 PST 
Date Created: 
User: 
01-03-2020 15:10:49 PST 
Number of Wells Used: 54 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 3 
Comments: 
















For Research Use Only. Not for use in diagnostic procedures. 












Blank L. helveticus 
Sample 2.1 L. helveticus 
Sample 2.2 L. helveticus 
Sample 2.3 L. helveticus 
 
Results Summary 





(Std Dev) (Mean) (Std Dev) 





















Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-3.5078 Y-Intercept:8.8185 R²:0.997 Eff%:92.788 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 
























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
B2 Sample 2.1 L. helveticus S 1.000 8.994 8.974 0.166 80.361 
B3 Sample 2.1 L. helveticus S 1.000 9.130 8.974 0.166 80.361 
B4 Sample 2.1 L. helveticus S 1.000 8.799 8.974 0.166 80.361 
B5 Sample 2.1 L. helveticus S 0.100 12.406 12.171 0.222 80.361 
B6 Sample 2.1 L. helveticus S 0.100 12.142 12.171 0.222 80.361 
B7 Sample 2.1 L. helveticus S 0.100 11.964 12.171 0.222 80.230 
B8 Sample 2.1 L. helveticus S 0.010 15.655 15.736 0.093 80.230 
B9 Sample 2.1 L. helveticus S 0.010 15.716 15.736 0.093 80.230 
B10 Sample 2.1 L. helveticus S 0.010 15.837 15.736 0.093 80.361 
B11 Sample 2.1 L. helveticus S 0.001 19.797 19.614 0.167 80.230 
B12 Sample 2.1 L. helveticus S 0.001 19.575 19.614 0.167 80.230 
B13 Sample 2.1 L. helveticus S 0.001 19.470 19.614 0.167 80.230 
B14 Sample 2.1 L. helveticus S 0.000 23.177 22.998 0.168 80.230 
B15 Sample 2.1 L. helveticus S 0.000 22.971 22.998 0.168 80.230 
B16 Sample 2.1 L. helveticus S 0.000 22.845 22.998 0.168 80.230 
B17 Blank L. helveticus N  UND.   61.278 
B18 Blank L. helveticus N  UND.   61.409 
B19 Blank L. helveticus N  UND.   61.409 
D2 Sample 2.2 L. helveticus S 1.000 9.151 9.034 0.114 80.361 
D3 Sample 2.2 L. helveticus S 1.000 8.924 9.034 0.114 80.361 
D4 Sample 2.2 L. helveticus S 1.000 9.027 9.034 0.114 80.361 
D5 Sample 2.2 L. helveticus S 0.100 12.162 12.018 0.150 80.361 
D6 Sample 2.2 L. helveticus S 0.100 11.862 12.018 0.150 80.230 
D7 Sample 2.2 L. helveticus S 0.100 12.031 12.018 0.150 80.361 
D8 Sample 2.2 L. helveticus S 0.010 15.674 15.571 0.089 80.230 
D9 Sample 2.2 L. helveticus S 0.010 15.524 15.571 0.089 80.230 
D10 Sample 2.2 L. helveticus S 0.010 15.515 15.571 0.089 80.230 
D11 Sample 2.2 L. helveticus S 0.001 19.377 19.416 0.136 80.230 
D12 Sample 2.2 L. helveticus S 0.001 19.568 19.416 0.136 80.230 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
D13 Sample 2.2 L. helveticus S 0.001 19.304 19.416 0.136 80.230 
D14 Sample 2.2 L. helveticus S 0.000 22.578 22.631 0.161 80.230 
D15 Sample 2.2 L. helveticus S 0.000 22.504 22.631 0.161 80.230 
D16 Sample 2.2 L. helveticus S 0.000 22.812 22.631 0.161 80.230 
D17 Blank L. helveticus N  UND.   61.409 
D18 Blank L. helveticus N  UND.   61.278 
D19 Blank L. helveticus N  UND.   61.146 
F2 Sample 2.3 L. helveticus S 1.000 9.033 9.076 0.120 80.361 
F3 Sample 2.3 L. helveticus S 1.000 8.983 9.076 0.120 80.361 
F4 Sample 2.3 L. helveticus S 1.000 9.211 9.076 0.120 80.361 
F5 Sample 2.3 L. helveticus S 0.100 12.319 12.157 0.145 80.361 
F6 Sample 2.3 L. helveticus S 0.100 12.114 12.157 0.145 80.361 
F7 Sample 2.3 L. helveticus S 0.100 12.038 12.157 0.145 80.361 
F8 Sample 2.3 L. helveticus S 0.010 15.334 15.496 0.140 80.230 
F9 Sample 2.3 L. helveticus S 0.010 15.568 15.496 0.140 80.230 
F10 Sample 2.3 L. helveticus S 0.010 15.585 15.496 0.140 80.361 
F11 Sample 2.3 L. helveticus S 0.001 19.646 19.782 0.143 80.230 
F12 Sample 2.3 L. helveticus S 0.001 19.770 19.782 0.143 80.230 
F13 Sample 2.3 L. helveticus S 0.001 19.930 19.782 0.143 80.230 
F14 Sample 2.3 L. helveticus S 0.000 22.715 22.839 0.121 80.230 
F15 Sample 2.3 L. helveticus S 0.000 22.844 22.839 0.121 80.230 
F16 Sample 2.3 L. helveticus S 0.000 22.956 22.839 0.121 80.230 
F17 Blank L. helveticus N  UND.   61.146 
F18 Blank L. helveticus N  UND.   61.541 
F19 Blank L. helveticus N  UND.   61.541 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 1 
Well Setup 54 Flagged Wells 0 Samples Used 4 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 0  
HIGHSD High standard deviation in 
replicate group 
0  
NOAMP No amplification 0  
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 0  
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 35 1 false 
Hold Stage 1 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 1.6 DEGREES_ 95.0 15 0.0 0 
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Experiment Name: 2020-01-06 165629 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_L_delbruki_L_paracasei_standardcurve_20200106.eds 
Run Started:  01-06-2020 22:08:39 PST 
Run Finished:  01-07-2020 00:30:04 PST 
Run Duration:  141 minutes 25 seconds 
Date Modified:  01-06-2020 19:28:30 PST 
Date Created: 
User: 
01-06-2020 16:56:29 PST 
Number of Wells Used: 108 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 2 
Comments: 
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For Research Use Only. Not for use in diagnostic procedures. 
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Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-2.8472 Y-Intercept:11.1791 R²:0.825 Eff%:124.503 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 





























B2 Sample 1 L. paracasei S 1.000 10.271 10.309 0.156 83.651  
B3 Sample 1 L. paracasei S 1.000 10.176 10.309 0.156 83.651  
B4 Sample 1 L. paracasei S 1.000 10.480 10.309 0.156 83.520  
B5 Sample 1 L. paracasei S 0.100 25.461 17.532 6.892 82.861  
B6 Sample 1 L. paracasei S 0.100 14.158 17.532 6.892 83.388  
B7 Sample 1 L. paracasei S 0.100 12.978 17.532 6.892 83.520  
B8 Sample 1 L. paracasei S 0.010 15.899 15.887 0.301 83.388  
B9 Sample 1 L. paracasei S 0.010 16.181 15.887 0.301 83.388  
B10 Sample 1 L. paracasei S 0.010 15.580 15.887 0.301 83.388  
B11 Sample 1 L. paracasei S 0.001 19.959 20.008 0.043 83.124  
B12 Sample 1 L. paracasei S 0.001 20.029 20.008 0.043 83.124  
B13 Sample 1 L. paracasei S 0.001 20.036 20.008 0.043 83.256  
B14 Sample 1 L. paracasei S 0.000 22.903 22.930 0.160 82.993  
B15 Sample 1 L. paracasei S 0.000 23.102 22.930 0.160 82.993  
B16 Sample 1 L. paracasei S 0.000 22.784 22.930 0.160 82.993  
B17 Blank L. paracasei N  UND.   61.383  
B18 Blank L. paracasei N  UND.   61.252 81.675 
B19 Blank L. paracasei N  UND.   82.070 61.383 
D2 Sample 2 L. paracasei S 1.000 UND. 10.504 0.910 61.383  
D3 Sample 2 L. paracasei S 1.000 9.861 10.504 0.910 83.651  
D4 Sample 2 L. paracasei S 1.000 11.147 10.504 0.910 83.520  
D5 Sample 2 L. paracasei S 0.100 13.487 13.627 0.377 83.388  
D6 Sample 2 L. paracasei S 0.100 13.340 13.627 0.377 83.388  
D7 Sample 2 L. paracasei S 0.100 14.054 13.627 0.377 83.388  
D8 Sample 2 L. paracasei S 0.010 16.419 16.222 0.198 83.256  
D9 Sample 2 L. paracasei S 0.010 16.024 16.222 0.198 83.388  
D10 Sample 2 L. paracasei S 0.010 16.225 16.222 0.198 83.388  
D11 Sample 2 L. paracasei S 0.001 20.061 20.120 0.175 83.124  
D12 Sample 2 L. paracasei S 0.001 20.317 20.120 0.175 83.124  
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 




























D13 Sample 2 L. paracasei S 0.001 19.983 20.120 0.175 83.124  
D14 Sample 2 L. paracasei S 0.000 22.096 22.050 0.191 82.993  
D15 Sample 2 L. paracasei S 0.000 22.213 22.050 0.191 82.993  
D16 Sample 2 L. paracasei S 0.000 21.840 22.050 0.191 82.993  
D17 Blank L. paracasei N  UND.   61.383  
D18 Blank L. paracasei N  UND.   61.252  
D19 Blank L. paracasei N  UND.   61.252  
F2 Sample 3 L. paracasei S 1.000 10.788 10.829 0.049 83.651  
F3 Sample 3 L. paracasei S 1.000 10.884 10.829 0.049 83.651  
F4 Sample 3 L. paracasei S 1.000 10.817 10.829 0.049 83.651  
F5 Sample 3 L. paracasei S 0.100 13.794 13.752 0.038 83.520  
F6 Sample 3 L. paracasei S 0.100 13.744 13.752 0.038 83.388  
F7 Sample 3 L. paracasei S 0.100 13.720 13.752 0.038 83.388  
F8 Sample 3 L. paracasei S 0.010 16.853 16.890 0.106 83.256  
F9 Sample 3 L. paracasei S 0.010 17.010 16.890 0.106 83.256  
F10 Sample 3 L. paracasei S 0.010 16.808 16.890 0.106 83.388  
F11 Sample 3 L. paracasei S 0.001 20.554 20.459 0.083 83.124  
F12 Sample 3 L. paracasei S 0.001 20.421 20.459 0.083 83.124  
F13 Sample 3 L. paracasei S 0.001 20.401 20.459 0.083 83.124  
F14 Sample 3 L. paracasei S 0.000 21.959 21.759 0.181 82.993  
F15 Sample 3 L. paracasei S 0.000 21.710 21.759 0.181 82.993  
F16 Sample 3 L. paracasei S 0.000 21.607 21.759 0.181 82.993  
F17 Blank L. paracasei N  UND.   73.901 61.383 
F18 Blank L. paracasei N  UND.   61.383  
F19 Blank L. paracasei N  UND.   61.252 89.317 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 2 
Well Setup 108 Flagged Wells 6 Samples Used 7 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 1 D2 
HIGHSD High standard deviation in 
replicate group 
5 B5, B6, B7, D3, D4 
NOAMP No amplification 0  
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 0  
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 35 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 0.05 DEGREES_ 95.0 15 0.0 0 
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Experiment Name: 2020-01-08 095816 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_L_plantarum_20200108_standardcurve.eds 
Run Started:  01-08-2020 15:31:56 PST 
Run Finished:  01-08-2020 18:09:53 PST 
Run Duration:  157 minutes 56 seconds 
Date Modified:  01-08-2020 13:08:14 PST 
Date Created: 
User: 
01-08-2020 09:58:16 PST 
Number of Wells Used: 54 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 3 
Comments: 
















For Research Use Only. Not for use in diagnostic procedures. 














Sample Target Quantity 
(Mean) 
Quantity                             









































Amplification Plot (Rn vs. Cycle) 
 
L. Plantarum 







Amplification Plot (Rn vs. Cycle) 
 L. Plantarum 
















slope:-3.4124 Y-Intercept:10.2015 R²:0.94 Eff%:96.358 
L. Plantarum) 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 
























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
B2 1.2 LP S 1.000 10.177 10.291 0.107 75.381 
B3 1.2 LP S 1.000 10.307 10.291 0.107 75.381 
B4 1.2 LP S 1.000 10.389 10.291 0.107 75.381 
B5 1.2 LP S 0.100 13.724 13.653 0.125 75.381 
B6 1.2 LP S 0.100 13.726 13.653 0.125 75.249 
B7 1.2 LP S 0.100 13.508 13.653 0.125 75.381 
B8 1.2 LP S 0.010 16.690 16.872 0.628 75.249 
B9 1.2 LP S 0.010 17.571 16.872 0.628 75.249 
B10 1.2 LP S 0.010 16.354 16.872 0.628 75.249 
B11 1.2 LP S 0.001 28.014 22.884 4.536 75.249 
B12 1.2 LP S 0.001 19.405 22.884 4.536 75.249 
B13 1.2 LP S 0.001 21.233 22.884 4.536 75.381 
B14 1.2 LP S 0.000 23.656 23.731 0.248 75.249 
B15 1.2 LP S 0.000 23.529 23.731 0.248 75.249 
B16 1.2 LP S 0.000 24.008 23.731 0.248 75.249 
B17 Blank LP N  UND.   61.411 
B18 Blank LP N  UND.   61.411 
B19 Blank LP N  UND.   61.411 
D2 2.2 LP S 1.000 10.147 10.431 0.410 75.381 
D3 2.2 LP S 1.000 10.900 10.431 0.410 75.381 
D4 2.2 LP S 1.000 10.244 10.431 0.410 75.249 
D5 2.2 LP S 0.100 13.012 13.314 0.276 75.249 
D6 2.2 LP S 0.100 13.379 13.314 0.276 75.249 
D7 2.2 LP S 0.100 13.552 13.314 0.276 75.249 
D8 2.2 LP S 0.010 16.465 16.609 0.203 75.249 
D9 2.2 LP S 0.010 16.521 16.609 0.203 75.249 
D10 2.2 LP S 0.010 16.842 16.609 0.203 75.249 
D11 2.2 LP S 0.001 20.260 20.494 0.487 75.249 
D12 2.2 LP S 0.001 20.168 20.494 0.487 75.249 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 























Qty Mean  Qty SD 
 
Tm1 Tm2 Tm3 
D13 2.2 LP S 0.001 21.053 20.494 0.487 75.249 
D14 2.2 LP S 0.000 23.849 23.804 0.039 75.249 
D15 2.2 LP S 0.000 23.787 23.804 0.039 75.249 
D16 2.2 LP S 0.000 23.776 23.804 0.039 75.249 
D17 Blank LP N  UND.   61.411 
D18 Blank LP N  UND.   61.411 
D19 Blank LP N  UND.   61.411 
F2 2.3 LP S 1.000 10.733 10.546 0.241 75.249 
F3 2.3 LP S 1.000 10.274 10.546 0.241 75.381 
F4 2.3 LP S 1.000 10.630 10.546 0.241 75.381 
F5 2.3 LP S 0.100 12.963 13.047 0.245 75.249 
F6 2.3 LP S 0.100 12.856 13.047 0.245 75.249 
F7 2.3 LP S 0.100 13.323 13.047 0.245 75.249 
F8 2.3 LP S 0.010 16.516 16.630 0.149 75.249 
F9 2.3 LP S 0.010 16.798 16.630 0.149 75.249 
F10 2.3 LP S 0.010 16.576 16.630 0.149 75.249 
F11 2.3 LP S 0.001 20.062 19.708 0.306 75.249 
F12 2.3 LP S 0.001 19.528 19.708 0.306 75.249 
F13 2.3 LP S 0.001 19.535 19.708 0.306 75.249 
F14 2.3 LP S 0.000 23.437 23.383 0.059 75.249 
F15 2.3 LP S 0.000 23.391 23.383 0.059 75.117 
F16 2.3 LP S 0.000 23.321 23.383 0.059 75.117 
F17 Blank LP N  UND.   61.411 
F18 Blank LP N  UND.   61.411 
F19 Blank LP N  UND.   61.411 
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 1 
Well Setup 54 Flagged Wells 7 Samples Used 4 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 0  
HIGHSD High standard deviation in 
replicate group 
6 B8, B9, B10, B11, B12, B13 
NOAMP No amplification 0  
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 1 F11 
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 40 1 false 
Hold Stage 1 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 1.6 DEGREES_ 95.0 15 0.0 0 
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Experiment Name: 2019-12-06 113816 
Experiment Type: Standard Curve 
BarCode: 
File Name: qPCR_LGG_20191206_standardcurve1.eds 
Run Started:  12-06-2019 19:25:19 PST 
Run Finished:  12-06-2019 21:26:44 PST 
Run Duration:  121 minutes 25 seconds 
Date Modified:  12-06-2019 16:18:10 PST 
Date Created: 
User: 
12-06-2019 11:38:16 PST 
Number of Wells Used: 54 
Number of Wells with Results: 54 
Instrument Name: 278862532 
Instrument Type:   
Instrument Serial Number: 278862532 
Model/Block Type:   
Stage/Step for analysis : Stage 2, Step 2 
Comments: 















L. rhamnosus GG 
 
For Research Use Only. Not for use in diagnostic procedures. 





















































Amplification Plot (Rn vs. Cycle) 
 







Amplification Plot (Rn vs. Cycle) 
 
















slope:-4.26 Y-Intercept:12.1956 R²:0.78 Eff%:71.689 






Melt Curve (Derivative Reporter) 






Melt Curve (Normalized Reporter) 


































B2 LGG LGG S 1.000 13.084 12.785 0.462  78.646   
B3 LGG LGG S 1.000 UND. 12.785 0.462  61.385 77.987  
B4 LGG LGG S 1.000 12.967 12.785 0.462  78.646   
B5 LGG LGG S 0.100 15.903 15.861 0.301  78.514   
B6 LGG LGG S 0.100 15.568 15.861 0.301  78.514   
B7 LGG LGG S 0.100 15.833 15.861 0.301  78.514   
B8 LGG LGG S 0.010 24.138 20.522 2.646  78.382   
B9 LGG LGG S 0.010 23.882 20.522 2.646  78.382   
B10 LGG LGG S 0.010 23.756 20.522 2.646  78.382   
B11 LGG LGG S 0.001 31.415 25.725 4.535  78.250   
B12 LGG LGG S 0.001 31.229 25.725 4.535  78.250   
B13 LGG LGG S 0.001 30.923 25.725 4.535  78.250   
B14 LGG LGG S 0.000 UND. 28.627 4.240  77.987 69.422 93.271 
B15 LGG LGG S 0.000 34.946 28.627 4.240  77.987   
B16 LGG LGG S 0.000 UND. 28.627 4.240  61.253   
B17 Blank LGG U  UND. 37.231  0.000 61.385   
B18 Blank LGG U  UND. 37.231  0.000 61.253   
B19 Blank LGG U  UND. 37.231  0.000 61.253 89.713  
H2 LGG LGG S 1.000 UND. 12.785 0.462  61.253   
H3 LGG LGG S 1.000 UND. 12.785 0.462  61.517   
H4 LGG LGG S 1.000 UND. 12.785 0.462  61.385   
H5 LGG LGG S 0.100 15.926 15.861 0.301  78.646   
H6 LGG LGG S 0.100 UND. 15.861 0.301  61.253   
H7 LGG LGG S 0.100 15.617 15.861 0.301  78.514   
H8 LGG LGG S 0.010 17.899 20.522 2.646  78.514   
H9 LGG LGG S 0.010 18.516 20.522 2.646  78.514   
H10 LGG LGG S 0.010 18.745 20.522 2.646  78.514   
H11 LGG LGG S 0.001 22.519 25.725 4.535  78.382   
H12 LGG LGG S 0.001 22.259 25.725 4.535  78.250   
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 

































H13 LGG LGG S 0.001 22.546 25.725 4.535  78.382   
H14 LGG LGG S 0.000 25.954 28.627 4.240  78.250   
H15 LGG LGG S 0.000 UND. 28.627 4.240  61.517   
H16 LGG LGG S 0.000 UND. 28.627 4.240  61.385   
H17 Blank LGG U  UND. 37.231  0.000 61.649   
H18 Blank LGG U  UND. 37.231  0.000 61.385   
H19 Blank LGG U  UND. 37.231  0.000 61.517   
O2 LGG LGG S 1.000 11.972 12.785 0.462  78.514   
O3 LGG LGG S 1.000 12.857 12.785 0.462  78.514   
O4 LGG LGG S 1.000 13.042 12.785 0.462  78.514   
O5 LGG LGG S 0.100 16.476 15.861 0.301  78.514   
O6 LGG LGG S 0.100 15.566 15.861 0.301  78.514   
O7 LGG LGG S 0.100 15.997 15.861 0.301  78.514   
O8 LGG LGG S 0.010 20.491 20.522 2.646  78.514   
O9 LGG LGG S 0.010 18.614 20.522 2.646  78.382   
O10 LGG LGG S 0.010 18.652 20.522 2.646  78.382   
O11 LGG LGG S 0.001 22.977 25.725 4.535  78.382   
O12 LGG LGG S 0.001 UND. 25.725 4.535  61.517 93.271 87.869 
O13 LGG LGG S 0.001 21.936 25.725 4.535  78.250   
O14 LGG LGG S 0.000 UND. 28.627 4.240  61.385   
O15 LGG LGG S 0.000 27.143 28.627 4.240  78.382   
O16 LGG LGG S 0.000 26.466 28.627 4.240  78.382   
O17 Blank LGG U  UND. 37.231  0.000 61.780 90.636  
O18 Blank LGG U  UND. 37.231  0.000 61.253   
O19 Blank LGG U 0.000 37.231 37.231  0.000 77.855   
Task Legends: S = Standard, N = NTC, U = Unknown, UND. = Undetermined 








Total Wells 384 Processed Wells 54 Targets Used 1 
Well Setup 54 Flagged Wells 41 Samples Used 2 
 
Flag Description Frequency Locations 
AMPNC Amplification in negative control 0  
BADROX Bad passive reference signal 0  
BLFAIL Baseline algorithm failed 0  
CTFAIL 
 
 0  
DRNMIN Define acceptable delta Rn 0  
EXPFAIL Exponential algorithm failed 19 B3, B14, B16, B17, B18, B19, H2, H3, H4, 
H6, H15, H16, H17, H18, H19, O12, O14, 
O17, O18 
HIGHSD High standard deviation in 
replicate group 
21 B8, B9, B10, B11, B12, B13, B15, H8, H9, 
H10, H11, H12, H13, H14, O8, O9, O10, 
O11, O13, O15, O16 
NOAMP No amplification 4 B14, H2, H16, O12 
NOISE Noise higher than others in plate 0  
NOSIGNAL No signal in well 0  
OFFSCALE Fluorescence is offscale 0  
OUTLIERRG Outlier in replicate group 1 O2 
PRFDROP Passive reference signal 0  
PRFLOW Low passive reference signal 0  
SPIKE Noise spikes 0  
THOLDFAIL Thresholding algorithm failed 0  
















m1,x1 m2,x2 m3,x3 m4,x4 m5,x5 
Run Mode 



















Stage No. of Repetitions Starting Cycle Auto Delta Enabled 
Hold Stage 1 1 false 
Cycling Stage 50 1 false 
Melt Curve Stage 1 1 false 
Thermal Protocol Details 
















































































































































































































Auto Delta Hold 
Time 
Disabled 0.05 DEGREES_ 95.0 15 0.0 0 
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